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Neuropeptides, which control emotion, behavior and body homeostasis, are released at 
nerve terminals through the exocytosis of dense-core vesicles (DCVs). Because neuropeptides 
are synthesized and packaged exclusively at the cell body, accurate and timely delivery of DCV 
to the distant nerve terminal, as well as tight regulation of neuropeptide release should be 
ensured to prevent the deprivation of releasable DCVs during activity. Traditionally, it was 
believed that DCVs are delivered to the nerve terminal exclusively through anterograde fast 
axonal transport. However, it is now known that DCVs continuously transit bidirectionally at 
nerve terminals that are highly branched with release sites located along strings of varicosities 
called en passant boutons. Therefore, it is not clear how DCV logistics operates to support 
neurosecretion. In addition, little is known about the release properties of neuropeptides in fully 
differentiated neurons. 
To address these issues, GFP-tagged neuropeptides were imaged in Drosophila 
melanogaster neuromuscular junction (NMJ) to study the routing and exocytosis behavior of 
DCVs in vivo. By using a newly developed optical technique, simultaneous photobleaching and 
imaging (SPAIM), to track single DCVs, it was found that DCVs circulate between the most 
distal bouton and the proximal axon. Neuropeptides are constantly delivered to en passant 
boutons via sporadic bidirectional capture of DCVs. These newly arrived DCVs can become 
releasable within minutes. Surprisingly, neuropeptides are discharged only partially and slowly 
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 v 
from DCVs, suggesting that “kiss-and-run” mode of exocytosis predominates over full fusion. 
Interestingly, these partially emptied DCVs can undergo multiple rounds of exocytosis, allowing 
some local recycling of DCVs and minimizing the need for the supply of new DCVs. Finally, it 
was found that DCVs are reloaded into en passant boutons after depolarization evoked-
neuropeptide release by activity-dependent capture that is regulated through the ryanodine 
receptor-CamKII signaling pathway.  
Altogether, this thesis describes some elegant mechanisms utilized by the neuron that 
efficiently maintain neuropeptide stores at the distant and morphologically complex nerve 
terminal.  
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1.0  INTRODUCTION 
1.1 NEUROPEPTIDES AND DENSE-CORE VESICLES 
Neuropeptides are neurohormones or neurotransmitters that consist of 3 to 100 amino acids and 
are expressed in various neuroendocrine cells and neurons. They are released into the 
extracellular fluid through the exocytosis of dense-core vesicles (DCVs). The name DCVs came 
from their electron-dense appearance under electron micrographs. They are much larger 
(diameter 100-500 nm) than classical small synaptic vesicles (SSVs; diameter 30-50 nm) that 
carry exclusively classical small molecule neurotransmitters (e.g. biogenic amines and amino 
acids). Neuropeptides are densely packaged in DCVs, in a less osmotically active form (such as 
sol-gel or crystalline state), which allows more contents to be stored and transported by DCVs 
(Michael et al., 2006).  
Neuropeptides exert effects on diverse tissue systems.  They control emotions, behavior, 
growth, and body homeostasis. Neuropeptides generally bind to G protein-coupled receptors 
(GPCRs), with the exception of a peptide-gated ionotropic receptor, which is a Na
+ 
 channel 
gated by the neuropeptide FMRFamide (Zhainazarov and Cottrell, 1998). Unlike classical small 
molecule neurotransmitters, secreted neuropeptides have longer half-lives and they often access 
their corresponding receptors at distant, non-synaptic sites (Agnati et al., 1995). Upon binding 
and activation of a neuropeptide receptor, downstream second messengers usually modulate 
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gating probabilities of ion channels and in turn, regulate neuron excitability (Salio et al., 2006), 
gene transcription (Landgraf and Neumann, 2004), synaptogenesis, and vasodilation (Cauli et al., 
2004). The first neuropeptide was identified about 30 years ago and since then 120 neuropeptides 
have been identified in humans (Salio et al., 2006). Immunocytochemistry and in situ 
hybridization studies revealed their expression in specific neuron subpopulations in both the 
central nervous system (CNS) as well as the peripheral tissues (Table 1). An increasing number 
of neuropeptide receptor antagonists and agonists have been developed for treatment of 
psychiatric diseases.   
   
Table 1 Common neuropeptides classified by tissue specificity 
 
Adapted from (Siegel, 1999) 
 3 
1.2 DCV DELIVERY TO THE NERVE TERMINAL 
1.2.1 Neuronal compartmentalization 
Unlike any other cell types, neurons are highly differentiated and polarized with extended 
processes (Figure 1). They are also one of the largest cells in humans, with the axonal 
compartment occupying more than 99% of their total cell volume (Morfini et al., 2009). 
Neuronal functions are compartmentalized in specific subcellular regions. Information flows 
unidirectionally in the form of action potentials from the somatodendritic region to the axon and 
down to the synaptic terminal, where information is relayed to effector cells through the 
exocytosis of chemical neurotransmitters.  
The soma encloses the cell nucleus, rough endoplasmic reticulum (ER) and Golgi 
apparatus. Proteins and lipids are predominantly synthesized and packaged in this region to 
supply other compartments of the neuron. Together with the soma, diverse projections of 
dendrites receive synaptic inputs through the activation of excitatory or inhibitors receptors, 
which leads to the opening of ion channels. Action potentials are initiated at the axon initial 
segment (AIS), located at the most proximal part of the axon. Threshold to excitation is 
remarkably smaller at the AIS than that at the somato-dendritic region (Kole et al., 2008), due to 
its high abundance of voltage gated Na
+
 channels at the AIS. The axon is often the longest 
process in an organism, its length can be up to 10,000 times the diameter of the cell body 
(Goldstein and Yang, 2000), transmitting signals possibly meters away. Vertebrate axons are 
commonly myelinated, allowing action potentials to propagate along the axon rapidly by 
activating Na
+
 channel clusters at the nodes of Ranvier. The axon is also a highway to deliver 
recourses synthesized at the cell body to the terminal. Unlike the classical textbook picture, the 
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nerve terminal is highly branched with synaptic release sites located at sequential varicosities 
called en passant boutons. Here, activation of voltage-gated Ca
2+
 channels by action potentials 
elicits the release of neurotransmitters. 
 
b) Subcellular polarity
a) Functional Polarity
Direction of action potential
Dendrites
Nerve terminals
En passant boutons
Somatodendritic input Axonal output
Soma AIS Axon
 
Figure 1 Neurons are highly polarized and differentiated 
a) Neurons are compartmentalized into functional units to propagate action potentials unidirectionally. Excitatory 
and inhibitory synaptic inputs are received and integrated at the somatodendritic area. At the AIS, new action 
potentials are generated. The resulting action potential then propagates along the axon. Finally, the electrical signal 
is transformed into chemical signals through the release of neurotransmitters. b) Subcellular localization of different 
molecular components at each functional domain. Dendrites are enriched with post-synaptic receptors that can be 
activated by neurotransmitters from the upstream neuron. Receptor activation elicits ion influx as well as other 
signaling cascades. Resources are synthesized at the soma and then transported to other compartments through 
microtubule-based transport. The AIS is characterized by high densities of voltage-gated sodium and potassium 
channels that generate and modulate action potentials. Ion channels along the axon rapidly propagate action 
potentials. Finally, at the nerve terminal, activation of voltage-gated Ca2+ channels by action potentiasl elicits the 
release of neurotransmitters at specialized release sites (active zones) in en passant boutons. The signal is then sent 
across the synaptic cleft by neurotransmitters to the post-synaptic partner.  
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1.2.2 Supply of neuropeptides from the soma 
The most fundamental difference between neuropeptides and classical neurotransmitters is their 
site of biosynthesis (Figure 2). Classical neurotransmitters are synthesized and packaged locally 
at the nerve terminal. Biosynthetic enzymes, transmitter precursors and other SSV components 
are synthesized at the soma and transported by axonal transport to the nerve terminal. Newly 
synthesized neurotransmitters are then packaged into SSVs (size: 20 nm radius) that originate 
from the intermediate endosomal compartment or plasma membrane. A synaptic vesicle cycle 
involving membrane endocytosis and transmitter repackaging operates at the nerve terminal to 
rapidly replenish SSVs for repeated rounds of transmitter release. Following release into the 
synaptic cleft, undegraded classical neurotransmitters are subject to reuptake into the nerve 
terminal and are repackaged into SSVs for another round of release.   
In contrast, since the biosynthetic machinery for neuropeptides is absent in the nerve 
terminal, the supply of neuropeptides requires the delivery of DCVs from the soma. 
Neuropeptides are synthesized as precursor peptides in the rough ER, and packaged into 
immature DCVs at the TGN. The newly budded DCVs fuse with other immature DCVs,  
missorted materials are then removed through budding (Park and Loh, 2008). After that, DCVs 
are believed to be delivered to the nerve terminal through one-way anterograde microtubule-
based fast-axonal transport (Goldstein and Yang, 2000). During the transport process, DCVs 
may undergo maturation that involves the proteolytic processing of neuropeptides. Upon arrival 
at the nerve terminal, DCVs are loaded onto the actin network (Huang et al., 1999), and are 
transferred to release sites on the plasma membrane either by diffusion or myosin-based 
transport (Eichler et al., 2006). The arrival of action potentials triggers the exocytosis of readily 
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releasable DCVs. Released neuropeptides are not subjected to reuptake and reuse through 
endocytosis.  
 
 
 
 
Figure 2 Life of the neurotransmitter  
Small molecule neurotransmitters and neuropeptides are synthesized and packaged, released and removed very 
differently. Top. Local synthesis and recycling of small molecule neurotransmitters. Bottom. Long distance 
secretory pathway of neuropeptides. [Modified from (Purves, 2001)] 
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1.2.3 Axonal transport of DCVs 
Long range axonal DCV transport takes place along the polarized microtubule track. A 
microtubule polymer is made of many α and ß tubulins. It has a dynamic plus-end undergoing 
continuous polymerization and depolymerization. In the axon, microtubules are plus-end 
oriented (i.e. the fast growing dynamic end is uniformally pointed towards the terminal) (Park et 
al., 2009). At the nerve terminal, microtubules may be organized as an array of irregular 
branches if the synapse is still plastic and dynamic. On the other hand, the formation of  
microtubule loops is indicative of an arrest in synaptic growth and bouton formation (Conde and 
Caceres, 2009). Microtubule-based motors serve as engines to move cargos along the track in 
specific direction. Typically, membranous organelles such as vesicles and mitochrondria are 
transported by fast (~1 µm/s) axonal transport, whereas cytoskeletal components and other 
soluble proteins are transported by slow axonal transport that is approximately 100 times slower 
(~1 mm/day).   
The kinesin superfamily proteins (KIFs) are plus-end directed motors for anterograde 
trasnsport. KIF1A/Unc-104 related kinesin-3,  a monomeric processive motor molecule (Figure 
3, left), is the key anterograde motor in the neuron for transport of synaptic vesicle precursor 
proteins (Okada et al., 1995) as well as neuropeptide containing DCVs (Barkus et al., 2008; Lo et 
al., 2011; Pack-Chung et al., 2007a; Zahn et al., 2004).  In the Drosophila unc104 mutant, imac, 
GFP-labeled neuropeptide DCVs are absent in both the axon and the neuromuscular junction 
(NMJ), but an abnormal accumulation was seen at the cell body. Not much is known about how 
KIF1A/unc104 interacts with DCVs to direct transport; however, it is possible that the active 
zone protein Liprin-α/SYD-2 serves as an adaptor protein for this process. In a colocalization and 
immunoprecipitation study, KIF1A was found to be associated with the vesicular membrane 
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Liprin-α (Shin et al., 2003). The same conclusion was obtained in a yeast-two hybrid study 
(Wagner et al., 2009). Live imaging in C.elegans using Unc-104 and SYD-2 as fluorescence 
resonance energy transfer (FRET) partners showed colocalized movements of these proteins 
(Wagner et al., 2009). Drosophila liprin-α mutants showed misaccumulation of synaptic vesicles 
and slower anterograde transport of Synaptobrevin-GFP transport in axons (Miller et al., 2005). 
Another study suggested that a Rab3 GDP/GTP exchange protein (Rab3-GEP), DENN/MADD, 
regulates cargo unloading through the direct interaction with the stalk domain of KIF1A. Rab3-
carrying vesicles are more effectively transported in the GTP state (Niwa et al., 2008). Because 
Rab3 is a well known G protein involved in DCV exocytosis, it is possible that this 
DENN/MADD and KIF1A interaction is also involved in DCV transport.  
  At the terminal, retrograde DCV transport is also needed to maintain nerve function. It 
may serve to remove aged and unused materials from the nerve terminal for degradation at the 
soma.  Antibody labeling of internalized native neuropeptides in rat sympathetic cervical ganglia 
revealed that incompletely released peptide contents are transported retrogradely back to the cell 
body (Li and Dahlstrom, 2007). Second, retrograde transport is also required to replenish 
neuropeptide stores at the terminal. Transiting retrograde DCVs were found to reload synaptic 
boutons immediately after activity-evoked release, a process termed activity-dependent capture 
(Shakiryanova et al., 2006b).  
 In the retrograde direction, it is believed that DCVs are transported by the universal 
minus-end directed motor, cytoplasmic dynein (Figure 3, right), although no data so far have 
proved the requirement of dynein in DCV transport. In the closest case, synaptic proteins were 
shown to misaccumulation at the ends of the neuronal processes in dynein mutant worms 
(Koushika et al., 2004). Most studies examining DCV retrograde transport showed the 
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involvement of the retrograde motor adaptor complex, Dynactin (Vaughan and Vallee, 1995); 
Figure 3). In one study, overexpression of p50/dynamitin and the first coiled-coil domain 
dominant negative mutant of p150
Glued
 (CC1) in cultured hippocampal neurons reduced axonal 
flux of DCVs in both anterograde and retrograde directions (Kwinter et al., 2009). Similarly, 
Drosophila arp1 mutants displayed a reduced velocity and run length of amyloid precursor 
protein (APP) -carrying vesicles in both directions (Haghnia et al., 2007). Surprisingly, a study 
has shown that the actin-based motor myosin V may also play a role in retrograde axonal 
transport of DCVs: overexpressing a myosin dominant-negative myosin Va construct impaired 
both the flux and speed of retrograde DCVs in hippocampal neuron (Bittins et al., 2010). 
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Figure 3 Anterograde and Retrograde motors for DCV transport 
Left.  DCVs are transported anterogradely by the KIF1A/Unc-104. No known adaptor has been reported for the 
cargo/motor association, but DENN/MADD/ Rab3 signaling may be involved in the loading/unloading of DCVs. 
Right. Retrograde transport is driven by cytoplasmic dynein. It consists of a pair of dynein heavy chains, which 
carries the microtubule binding, ATPase motor domain (Pfister et al., 2006) and a pair of intermediate and light 
chains that links the motor to the cargo. The dynactin multisubunit complex serves as an adaptor molecule for 
cargo/motor association (Vaughan and Vallee, 1995). p150Glued is the largest subunit and is involved in microtubule 
binding, cargo loading  and retrograde transport initiation (Vaughan, 2005). Dynamitin serves as a scaffold for all 
the other subunits. Overexpression of dynamitin is commonly used as a tool to inhibit retrograde transport 
(Melkonian et al., 2007). The Actin- related protein (Arp) filament is involved in bidirectional coordination of the 
cargo (Haghnia et al., 2007). Note that the diagram is showing only the better characterized dynactin subunits. 
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1.2.4 Bidirectional DCV transport  
 Traditionally, it was believed that neuropeptides are transported exclusively in the anterograde 
direction to the nerve terminal, but it is now known that DCVs continuously moves 
bidirectionally along neuronal processes. Such bidirectional movement was first observed 
directly by time-lapse imaging of DCVs labeled with GFP-tagged phogrin in C. elegans axons 
(Zahn et al., 2004). Later, in vivo imaging of GFP tagged-atrial natriuretic factor (Anf-GFP) 
revealed that DCVs are transiting bidirectionally along axons and en passant boutons of resting 
motoneurons (Shakiryanova et al., 2006a). In cultured hippocampal neurons, neuropeptide Y 
(NPY) DCVs transit bidirectionally in the axon (Kwinter et al., 2009). Interestingly, a 
bimolecular fluorescence complementation (BiFC) assay in C. elegans found that Unc-104 is 
interacting directly with Syd-2(Liprin-α) and DCTN1 (p150Glued) in a motor-adaptor complex. 
While Unc-104 was mostly associated with Syd-2 along the axon, it mainly associated with 
DCTN1 at the terminal, and the interaction slowed down anterograde and retrograde movements 
respectively (Hsu et al., 2011). These observations suggested that the bidirectional movement of 
DCVs may be regulated by the interaction of motor/adaptor complex with opposite directions in 
different compartments of the neuron.  
Bidirectional transport coordination is a possible mechanism to regulate DCV loading 
and unloading on the microtubule, which may in turn, determine the specific site of DCV 
delivery. Nevertheless, DCV trafficking has mainly been studied in neuroendocrine cells which 
lack neuronal processes. Thus the mechanism by which bidirectional DCV movement is 
regulated remains unclear. Data thus far have suggested that neuronal activity can either inhibit 
or enhance DCV transport depending on the experimental system. At fly NMJs, activity reduces 
retrograde but not anterograde DCV flux across en passant boutons (Shakiryanova et al., 2006a), 
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allowing retrograde DCVs to be delivered to proximal boutons after release. In differentiated 
hippocampal neuron cultures, cell depolarization enhanced synaptic capture of intracellular 
neurotrypsin transport vesicles (Frischknecht et al., 2008). In the trigeminal ganglion axon, 
activity-evoked depolarization increased anterograde DCV flux and decreased retrograde flux 
(Sobota et al., 2010). Anterograde transport velocity of peptidergic vesicles in neuroblastoma 
NS20Y was found to be increased by forskolin, the adenyl cyclase activator (Washburn et al., 
2002).  
1.2.5 Axonal transport and neurodegenerative diseases 
Axonal transport is crucial for the supply of newly synthesized materials and energy sources, 
such as DCVs, synaptic components and mitochrondria, from the soma to the distal terminal to 
support nerve functions (Hollenbeck and Saxton, 2005). It is also important for the elimination of 
lysosomes and autophagosomes, which carry aged and damaged materials, from the axon and 
terminal to the soma for degradation (Chevalier-Larsen and Holzbaur, 2006). An increasing body 
of evidence suggests that axonal transport is also important in supporting retrograde signaling 
(Zweifel et al., 2005). For all the above reasons, defective axonal transport is believed to be a 
possible cause of neurodegeneration. Indeed, increasing lines of evidence shows that abnormal 
axonal transport is associated with many neurodegenerative diseases.  
Pathologically, abnormal swelling and accumulation of protein aggregates in the axon is 
a hallmark in patients with neurodegeneration, suggesting that axonal transport is compromised 
in the neurons of these patients. Autopsy of a distal spinal and bulbar muscular atrophy 
(dSBMA) patient showed abnormal inclusions of dynactin and dynein in motor neurons (Puls et 
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al., 2005). Cytoskeleton abnormalities are also seen in the dystrophic neurites of Alzheimer 
disease patients (Praprotnik et al., 1996).  
Human genetic studies have shown that mutations of motor/adaptor proteins cause many 
neurodegenerative diseases.  A mutation of KIF1A was found in hereditary sensory and 
autonomic neuropathy type 2 (HSANII) (Riviere et al., 2011). Point mutations in the CAP-Gly 
domain of the dynactin p150
Glued
 subunit (DCTN1 gene) were found in patients with two 
different forms of familial neurodegeneration (Puls et al., 2003), Perry syndrome (Farrer et al., 
2009) and amyotrophic lateral sclerosis (ALS). Perry syndrome is an autosomal dominant 
disorder which consists of early-onset parkinsonism, depression, severe weight loss and 
hypoventilation (Farrer et al., 2009). ALS is the most common adult-onset motoneuron disease 
characterized by muscle weakness, muscle atrophy, and spasticity. Transgenic mice expressing 
the human p150
Glued
 protein mutated in ALS developed motoneuron diseases. Impaired vesicular 
transport in cell bodies, axonal swelling and axo-terminal were seen in the diseased motor 
neurons (Munch et al., 2004).  
Indeed, multiple animal models of neurodegeneration were generated based on targeted 
mutations of the retrograde motor molecules. Legs at odd angles (Loa) mice express a mutant 
form of cytoplasmic dynein heavy chain. Heterozygous Loa mice exhibited impaired muscle 
function and motor coordination (Chen et al., 2007; Hafezparast et al., 2003). In vivo imaging of 
the dorsal root ganglion (DRG) neuron culture from Loa
+/-
 mice showed impaired retrograde 
transport of survival factors such as brain-derived neurotrophic factor (BDNF) and nerve growth 
factor (NGF) (Perlson et al., 2009). Another mouse model was generated by overexpressing the 
dynactin subunit dynamitin to disrupt dynein-dynactin complex interaction in postnatal 
motoneurons. These mice developed motoneuron degeneration characterized by muscle 
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weakness, and deficits in strength and endurance. In the motoneuron, neurofilament 
misaccumulation and the delay in retrograde neurotracer arrival at the cell body suggest an 
impairment of retrograde transport in these neurons (LaMonte et al., 2002). 
1.3 ACTIVITY-DEPENDENT NEUROPEPTIDE RELEASE AT NERVE 
TERMINALS 
Neuropeptides are released at the nerve terminal through the regulated secretory pathway. Upon 
action potential arrival, voltage gated Ca
2+
 channels (VGCCs) open and Ca
2+
 influx activate 
various Ca
2+
 sensors, eliciting a sequence of molecular events that trigger DCV exocytosis. 
Unlike SSVs, exocytosis of DCVs requires lower intracellular Ca
2+
 concentration (~ less than 
1 μM) and the rise in Ca2+ concentration does not need to be focal (Ghijsen and Leenders, 2005). 
Rather, Ca
2+
 concentration at regions far away from the Ca
2+
 microdomain is produced by 
sustained action potential trains. It is believed that the long latency of DCV fusion after initial 
Ca
2+
 influx (3-50ms) is due to the slow Ca
2+
 concentration build up at the cytoplasmic region 
(Martin, 2003). The exact molecular mechanism by which the exocytosis of DCV and SSV are 
regulated remains unclear. Nevertheless, certain biophysical properties for DCV exocytosis are 
distinct from those for SSVs. In the following sections, some of these biophysical properties, 
such as their release probability and kinetics, will be described.  
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1.3.1 Releasability of DCVs 
In many peptidergic neurons and neuroendocrine cells, only a fraction of DCVs stored at the 
terminal are release-competent (i.e., the readily releasable pool, RRP; (Thorn, 1966). It has long 
been postulated that the RRP comprises DCVs that are immobilized, docked close to the plasma 
membrane and equipped with synaptic proteins for membrane fusion. Nevertheless, studies have 
revealed that DCV mobility is more crucial in determining releasability. Direct imaging of 
neuropeptide in growth cones of PC12 cells showed that rapidly moving DCVs near the plasma 
membrane are more releasable. In addition, mobile cytoplasmic DCVs can bypass the docking 
state to undergo exocytosis (Han et al., 1999; Ng et al., 2003). Similarly, in developing 
hippocampal neurons, exocytosis is favored by heterogeneously mobile DCVs, and fusion is 
often preceded by substantial DCV movement (Silverman et al., 2005).  In the fly NMJ, activity-
dependent mobilization of DCVs was found to facilitate post-tetanic potentiation (PTP) of 
neuropeptide release (Shakiryanova et al., 2007; Shakiryanova et al., 2005). Finally, DCV 
mobility is correlated with fusion probability, and that submicrometer motion is required for 
exocytosis (Degtyar et al., 2007).  
The releasability of DCVs also depends on its age. The notion that newly synthesized 
hormone is preferentially released was first proposed many years ago. In a parathyroid hormone 
(PTH) radiolabling experiment, pulse labeled PTH was found to be released faster than 
preexisting unlabelled PTH (MacGregor et al., 1975).  With the advent of a timer fluorescent 
probe, DCVs of different ages could be selectively labeled with green (young) and red (old) 
using DsRed-E5.  It was found that younger DCVs are distributed close to the cell membrane 
and are relatively immobile. On the other hand, older DCVs reside deeper inside the cell. Most 
importantly, membrane proximal, immobile and young DCVs preferentially release their 
 16 
contents upon nicotine stimulation (Duncan et al., 2003; Wiegand et al., 2003). Recently, with 
the use of a newer fluorescent reporter, monomeric Kusabira Green Orange (mK-GO), which 
changes from green to red with a predictable time course (t1/2= 6h), it was also found that 
younger DCVs undergo release exclusively in PC12 cells. Moreover, such age dependent 
preference of DCV exocytosis is regulated by the small GTPase Rab27A effectors, rabphilin and 
Slp4-a (Tsuboi et al., 2010) 
1.3.2 Kiss and run exocytosis  
Similar to SSVs, there are 2 possible consequences of DCVs after they fuse with the plasma 
membrane during exocytosis. DCVs may undergo full collapse fusion, which is classical mode 
of exocytosis. In this case, the entire vesicle collapses completely into the plasma membrane, 
allowing the instant release of all its contents. The vesicle membrane is later retrieved by 
clathrin-dependent endocytosis. The empty vesicle is then uncoated and recycled through the 
endosomal compartment (Heuser and Reese, 1973) (Figure 4, bottom). DCV may undergo 
transient fusion, a process now termed as kiss-and-run exocytosis or cavicapture (Ceccarelli et 
al., 1973; Fesce et al., 1994; Tsuboi et al., 2004).  Kiss-and-run is a direct retrieval pathway in 
which vesicles fuse only transiently with the plasma membrane, maintaining their integrity and 
shape, and are endocytosed immediately without the need of clathrin. Vesicular contents are 
released only partially into the extracellular space by diffusion through the fusion pore opening. 
The fusion pore then closes and the same vesicle remains docked close to the plasma membrane, 
ready for another round of exocytosis (Figure 4, top). The choice for either type of exocytosis is 
associated with Ca
2+ 
concentration (Ales et al., 1999). High frequency stimulation and hence low 
Ca
2+
 influx generally favor faster fusion events and full collapse of vesicles. On the other hand, 
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low frequency stimulation favors slower fusion and kiss-and-run exocytosis (Fulop and Smith, 
2006). 
Kiss-and-run is a very common mode of exocytosis for DCVs. It was first described in 
the 1990s with the use of amperometry and capacitance measurements. The flickering of 
membrane capacitance with concomitant release of serotonin suggested a fast, direct mode of 
DCV endocytosis right after exocytosis (Artalejo et al., 1995; Chow et al., 1992).   Later, DCV 
fusion and content release could be monitored at a single vesicle level using fluorescence 
imaging. By imaging single DCVs labeled with Phogrin-GFP and the acridine orange cargo 
simultaneously, it was found that vesicles retained their integrity even after cargo release (Pouli 
et al., 1998). Kiss-and-run exocytosis of peptide containing DCVs was first revealed in 
pancreatic MIN6 beta cells, where neuropeptide Y(NPY)-Venus was found to be  released from 
DCVs without full membrane fusion (Tsuboi and Rutter, 2003). It is now evident that DCVs in 
developing neurons can also undergo kiss-and-run exocytosis. Direct imaging of single DCV 
exocytosis in hippocampal neurons showed that more than half of the DCVs in the neurites 
exhibited prolonged and incomplete release (Xia et al., 2009).  
1.3.3 Fusion pore and neuropeptide release kinetics 
The narrow opening of fusion pore during kiss-and-run implies that the rate of release may be 
limited by the size of the neuropeptide. In PC12 cells, tissue plasminogen activator (tPA)-Venus 
is released 40 times slower than NPY-GFP, which is three times smaller. Nevertheless, NPY-
GFP-GFP, which has an intermediate size, releases the slowest, arguing that factors other than 
relative size of the cargo and fusion pore can affect the speed of fusion (Felmy, 2007). For 
example, biochemical interaction between the peptide and the luminal matrix may affect the 
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cargo diffusion rate. Indeed, Semaphorin3A (Sema3A) and BDNF were found to be released as a 
stable deposit. The released deposit stays on the extracellular membrane for a prolonged period 
(~2 min) and diffuses gradually. Such events were not correlated with the size of the cargo, 
rather they depend on the specific cargo and their interactions with the luminal matrix (de Wit 
2009). 
The duration and size of fusion pore opening determine how much content can be 
released. The current model suggests that the GTPase scission protein, dynamin I, is a key 
regulator for fusion pore opening (Chan et al., 2010). Overexpression of GTPase defective 
mutant increases the dwell time of fusion while overexpression of the PH domain mutant induces 
full fusion of vesicles (Tsuboi et al., 2004). The activity of dynamin I depends on the 
dephosphorylation by calcineurin (Cousin et al., 2001). Recent studies suggested that fusion pore 
constriction by Ca
2+
-dependent amphiphysin is a key step before dynamin scission (Llobet et al., 
2008). Contrasting data were found regarding the role of myosin II in fusion pore regulation. 
While increased expression and phosphorylation levels of myosin II accelerates fusion pore 
dilation thus increasing the amount of hormone release, inhibition of myosin II phosphorylation 
stabilizes fusion pore dilation (Aoki et al., 2010; Berberian et al., 2009; Neco et al., 2008). The 
actin network is another regulator for DCV fusion pore constriction, mainly by stabilizing the 
membrane invagination during exocytosis. Overexpression of β-actin and treatment with the 
actin destablizer cytochalasin slowed the release of a large neuropeptide, tissue plasminogen 
activator (tPA), during kiss and run (Felmy, 2007). 
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1.3.4 Role of kiss and run exocytosis is controlling release 
Kiss-and-run exocytosis plays an important role in controlling neuropeptide secretion. The slow 
and partial release of neuropeptides prevents store deprivation under repetitive firing. The rapid 
retrieval of DCVs without undergoing clathrin-dependent endocytosis allows efficient  reuse of 
resources. The narrow fusion pore during exocytosis serves as a filter to select transmitters to be 
released based on their size. The fusion pore size is in turn regulated by electrical activity and 
other molecular regulators. Such a size-exclusion mechanism is important because DCVs often 
contain with multiple subclasses of transmitters (e.g. peptides vs biogenic amines) (Elhamdani et 
al., 2006; Zhang et al., 2009). Peptide cargo release was also found to be prevented from release 
through the small fusion pore under spontaneous activity (Vardjan et al., 2007) (Figure 4). 
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Figure 4  Kiss-and-run versus full collaspe fusion 
Top path.  In kiss-and-run exocytosis, vesicular contents are released incompletely before the fusion pore constricts 
and retrieves the vesicle again. The transient fusion pore formed may serve as a size filter to prevent high molecular 
weight contents, eg. peptides, from releasing. Bottom path, vesicle is collapsed completely into the plasma 
membrane and all the vesicular contents are discharged. The fusion pore size is regulated by both the activity of 
dynamin and the pore expansion complex. Adapted from (Chan et al., 2010). 
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1.4 THE EXPERIMENTAL SYSTEM : IN VIVO DCV IMAGING IN NEURONS  
1.4.1 Tools to study DCV transport and exocytosis  
Axonal transport was originally studied by localizing organelles using electron microscopy after 
nerve ligation treatment (Brauckmann, 2004). Later, a new technique was invented to pulse 
chase newly synthesized radiolabeled proteins along the axon of a dorsal root ganglion cell. By 
analyzing the composition of the radioactive proteins at different regions of the axon at different 
time points, the rate of protein transport could be determined (Tobias and Koenig, 1975). With 
the development of immunocytochemistry, the transport properties of specific proteins of interest 
could be examined with the use of mutants and nerve ligation (Dahlstrom, 2010). Nevertheless, 
these strategies are limited to steady state imaging of fixed preparations. Many dynamic transport 
processes are not resolved and artifacts are often introduced into fixed preparations. 
DCV exocytosis is often studied by patch clamp capacitance measurements (Neher and 
Marty, 1982). The change in capacitance is correlated with the change surface area. Therefore, 
fusion and endocytic events of single vesicles to the plasma membrane are reflected as discrete 
steps of capacitance increase and decrease, respectively  (Kanno et al., 2004). The magnitude of 
the capacitance steps can be used to estimate the diameter of the single vesicle and thus 
differentiating DCVs and SSVs (also termed as microvesicles) (Figure 5A). In the 90s, 
amperometry was invented to measure the quantal release of readily oxidizable transmitters from 
DCVs with the use of electrodes placed close by the release site (MacDonald and Rorsman, 
2007) (Figure 5B). Nevertheless, capacitance or amperometry measurements provide only 
membrane fusion or content release kinetics, unless both techniques are used simultaneously. In 
addition, no spatial information about the vesicle (e.g. localization and mobility) is obtained with 
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these methods. More importantly, neuropeptides are not easily oxidizable and therefore such 
studies have been limited to release of monoamine neurotransmitters.  
The advent of fluorescent proteins in the 90s resolved many of the above issues in 
studying DCV transport and exocytosis. By labeling DCVs using fluorescent proteins, DCV 
distribution, motion and exocytosis, as well as the release of neuropeptides can be monitored in 
real-time from a live preparation using a conventional fluorescent microscope. Fluorescence 
recovery after photobleaching (FRAP) can also be used to track the motion of labeled vesicles in 
a region that is normally filled by too many DCVs for visualization (Levitan et al., 2007). 
Furthermore, DCVs can be labeled with timer proteins that change their excitation/emission 
spectra with time, so that DCVs of different ages are selectively labeled with different colors. 
The distribution of DCVs with different colors at different cellular compartments allows one to 
track DCVs according to their age.  Examples of these probes include DsRed-E5 and mK-GO 
(Brigadski et al., 2005; Tsuboi et al., 2010). Finally, with the use of photoconvertable fluorescent 
proteins that change fluorescent color upon laser activation, DCVs can be pulse-chased even 
more precisely with no dependence on vesicle age. Photoactivation can be used to acutely label a 
small population of DCVs at a specific region, and the translocation of these labeled DCVs can 
be followed to other cellular locations. Commonly used photoactivatable fluorescent proteins 
include: Kaede and Eos-FP (Lukyanov et al., 2005).  
Neuropeptide release can be measured by labeling DCVs with fluorescent protein tagged 
neuropeptides. The decrease in fluorescence after activity represents the amount of release. 
Membrane fusion during exocytosis can be monitored by pH sensitive fluorescent proteins 
(Figure 5).  In mammalian cells, the vesicle lumen normally has an acidic pH (pH<6), while the 
physiological extracellular medium is alkaline (pH>7). Therefore, by tagging a pH-sensitive 
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fluorescent protein to the luminal domain of any integral vesicle protein, (e.g. vesicle-associated 
membrane protein (VAMP)/ synaptobrevin, or phogrin), fusion events can be detected as an 
increase of fluorescent signal due to the neutralization of the surrounding medium.  
 
Figure 5 Common tools to study DCV exocytosis 
A. Cell attached capacitance measurements monitor the change in surface area of a small patch of cell membrane. 
Single vesicle exocytosis is detected as a step-wise increase in capacitance.  B. Amperometry measures the release 
of oxidizable transmitters, such as 5-HT. An electrode is placed close to the membrane and the release of a single 
vesicle can be detected as an amperometry spike. C. Fluorescence imaging can be done by total internal reflection 
fluorescence (TIRF) or confocal microscopy, both of which can limit the number of visible vesicles by focusing on a 
thin focal plane.  Single vesicle release events can be detected by the change in fluorescent intensity of a punctum. 
Lateral movement of the vesicle can also be monitored. Adapted from (MacDonald and Rorsman, 2007) 
1.4.2 Animal models and experimental systems:  
Research of DCV biology has mainly been based on tissue culture systems. Primary endocrine 
cell cultures including pancreatic or medullary chromaffin cells are the most commonly used 
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systems. The pheochromocytoma (PC12) cell line is another well-established system because it 
is robust and easy to culture. More importantly, PC12 cells can be induced by nerve growth 
factors to differentiate into sympathetic neurons, which exhibit extended processes and growth 
cone structures. Although native DCVs in PC12 cells contain mainly dopamine and sometimes 
noradrenaline, fluorescent protein tagged neuropeptides can be ectopically expressed by 
transfection. This allows DCV trafficking and release to be directly monitored. Nevertheless, 
differentiated PC12 cells still lack typical neuron morphology, such as branches and en passant 
boutons, meaning that their use to study axonal transport is limited. In addition, it has been 
argued that PC12 cells have a tumorigenic lineage and the secretory pathway may be altered. 
Thus, findings from PC12 cells may not represent normal physiological characteristics. 
Many limitations of the PC12 system can be overcome by using Drosophila larval NMJ. 
In this model, third instar larvae are dissected dorsally and the NMJ located on the surface of 
exposed abdominal muscles can be imaged using conventional upright microscopy (Brent et al., 
2009) (Figure 1-3). With careful dissection and correct bathing medium (hemolymph-like 
saline), the preparation can stay alive for hours without additional temperature and gas control, 
thus allowing simple imaging and electrophysiological studies at the NMJ (Imlach and McCabe, 
2009).  Compared to vertebrate models, the fly larva has a simpler and more identifiable 
neuronal system. Axon bundles projecting from the ventral ganglion allows easy electrical 
manipulation of NMJ in a specific muscle segment (Figure 6).  A huge number of fly genetic 
mutants have been identified and are publicly available; besides, ectopic gene expression also 
allows simple genetic manipulation of proteins of interest with high spatial/ temporal specificity 
(Duffy, 2002). Proteins of interest tagged with different fluorescent proteins can be expressed in 
specific tissues, and protein expression levels, localization and cellular dynamics can be 
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monitored in vivo with ease (Levitan et al., 2007; Schmid and Sigrist, 2008; Smith and Taylor, 
2011). In addition, transgenic UAS constructs for mutant, dominant negative or constitutive 
active proteins, and RNA interference (RNAi)  can be overexpressed timely to specific tissues of  
wild-type or mutant organisms for different genetic perturbation or rescue experiments  
(McGuire et al., 2004).  
In a 3
rd
 instar larva, there are 32 motoneurons innervating 30 post-synaptic muscle cells 
in each abdominal hemisegment. Conventionally, these motoneurons are classified into three 
classes based on their bouton morphology. Type I bouton are the best characterized NMJ. They 
form predominantly excitatory glutamatergic synapses with the partnering muscle. Their 
morphology (e.g. branch points, bouton number and size) is stereotypical. They are further 
classified into type-Ib (b: big) with a diameter of 3-5 μm, or type-Is (s: small) with a diameter of 
1-1.5 µm (Prokop, 2006). Ultrastructural analysis from electron micrographs, showed that about 
200 DCVs are present in a type Ib bouton (Atwood et al., 1993). Proctolin and PACAP38-like 
peptides are the only two neuropeptides that have been identified in type I boutons (Anderson et 
al., 1988b; Zhong and Pena, 1995). Type III boutons are more elongated (2-5um), and DCVs are 
more densely packed (50 fold) in these boutons (Jia et al., 1993). The majority of fly 
neuropeptides, such as leukokinin-like and the insulin-like peptide, are expressed in the 
peptidergic type III motoneurons (Gorczyca et al., 1993; Landgraf et al., 2003).  
 About 10 years ago, our group generated a transgenic fly that expresses Emerald GFP-
tagged atrial natriuretic factor (Anf-GFP), a mammalian neuropeptide that stimulates diuresis 
and vasodilation (Inagami, 1989), in neurons (elav-Gal4 UAS-preproANF-EMD)(Rao et al., 
2001a). In vivo imaging showed that Anf-GFP labeled DCVs transport bidirectionally along 
resting axons and NMJs. Upon simulation, Anf-GFP is released and the amount could be 
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quantified from the drop in fluorescence (Levitan et al., 2007; Rao et al., 2001a; Shakiryanova et 
al., 2005; Shakiryanova et al., 2006a). 
 
 
Figure 6 A dissected fly larval preparation 
1.5 THESIS GOAL 
Neurons undergo repetitive firing for neurotransmission and transmitters in the terminal are 
subjected to continuous depletion. Therefore, accurate and timely delivery of DCVs to the nerve 
terminal, as well as the tight regulation of neuropeptide release should be ensured. However, the 
supply logistics and exocytosis properties of DCVs within a fully differentiated nerve terminal 
still remain unknown.  To address the above issues, this thesis attempts to answer the following 
questions by imaging GFP-tagged neuropeptides at the fly NMJ in vivo: 1) How are 
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bidirectionally transiting DCVs delivered to branches and en passant boutons? 2) What are the 
release properties (e.g. mobility, releasability and exocytosis kinetics) of DCVs in a live, 
differentiated nerve terminal? 3) What is the signaling pathway involved in the replenishment of 
the neuropeptide store after activity?   
Chapter 2  has been published as “Neuropeptide delivery to synapses by long-range 
vesicle circulation and sporadic capture” in Cell (Wong et al., 2012). It will describe how a novel 
circulation route taken by DCVs to deliver neuropeptides bidirectionally via sporadic capture. It 
will present the use of a newly developed optical technique, simultaneous photobleaching and 
imaging (SPAIM), to track single DCVs. In Chapter 3, I will use SPAIM to examine the 
exocytosis properties of single DCVs upon electrical stimulation.  It will show newly arrived 
DCVs undergo exocytosis exclusively by kiss-and-run exocytosis, and can undergo multiple 
rounds of exocytosis to further discharge their contents. Chapter 4 has been published as 
“Presynaptic ryanodine receptor-CamKII signaling is required for activity-dependent capture of 
transiting vesicles” in Journal of Molecular Neuroscience (Wong et al., 2009). It will examine 
the requirement of ryanodine receptor -CamKII signaling in activity-dependent DCV capture. In 
the end, I will summarize the major findings of the thesis and discuss the implication and future 
directions of the studies.   
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2.0  NEUROPEPTIDE DELIVERY TO SYNAPSES BY LONG RANGE VESICLE 
CIRCULATION AND SPORADIC CAPTURE 
2.1 ABSTRACT 
Neurotransmission requires anterograde axonal transport of dense-core vesicles (DCVs) 
containing neuropeptides and active zone components from the soma to nerve terminals.  
However, it is puzzling how one-way traffic could uniformly supply sequential release sites 
called en passant boutons.  Here Drosophila neuropeptide-containing DCVs are tracked in vivo 
for minutes with a new method called simultaneous photobleaching and imaging (SPAIM).  
Surprisingly, anterograde DCVs typically bypass proximal boutons to accumulate initially in the 
most distal bouton.  Then excess distal DCVs undergo dynactin-dependent retrograde transport 
back through proximal boutons into the axon.  Just before reentering the soma, DCVs again 
reverse for another round of anterograde axonal transport.  While circulating over long distances, 
both anterograde and retrograde DCVs are captured sporadically in en passant boutons.   
Therefore, vesicle circulation, which includes long range retrograde transport and inefficient 
bidirectional capture, overcomes the limitations of one-way anterograde transport to uniformly 
supply release sites with DCVs. 
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2.2 INTRODUCTION 
Neurotransmission relies on axonal transport of neuropeptides and active zone components 
packaged in dense-core vesicles (DCVs) to the nerve terminal  (Ahmari et al., 2000; Zupanc, 
1996).  Many terminals feature sequential varicose sites called en passant boutons, which release 
neuropeptides to regulate neuronal circuits or large postsynaptic targets, such as muscle cells.  In 
en passant boutons, neuropeptide stores are typically uniform reflecting equivalent accumulation 
of DCVs that reside in each bouton for many hours (Shakiryanova et al., 2006a).  The kinesin 
responsible for anterograde axonal transport of DCVs has been identified (Barkus et al., 2008; 
Jacob and Kaplan, 2003).  However, it is not known how anterograde transport equivalently 
supplies DCVs to en passant boutons to ensure that neurotransmission is robust. 
 The difficulty in distributing DCVs generated in the soma among en passant 
boutons is evident when possible models based on one-way anterograde transport are considered.  
For example, if boutons were filled in order, then the most proximal bouton would be supplied 
first and distal boutons might be starved for resources.  Even with stochastic delivery, this 
problem persists:  with a fixed probability of delivering anterograde DCVs to each bouton, 
delivery would still be highest for the most proximal bouton and decrement for each subsequent 
bouton.  In principle, this issue could be overcome by routing cargoes specifically to each en 
passant bouton, but there is no known address system for directing delivery of DCVs from the 
soma to a potentially large and dynamically changing number of boutons.  Therefore, although 
en passant boutons are common throughout the nervous system, the mechanism for uniformly 
maintaining their DCV pools by anterograde transport is unknown. 
 Here the “rules of the road” for neuronal DCVs are determined by combining 
Drosophila genetic methods with a technique that enables tracking of neuropeptide-containing 
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DCVs in native nerve terminals for minutes.  Anterograde axonal transport, which had been 
thought to fully account for delivery to the terminal, is shown to be just the first step in a 
surprising, but elegant, routing strategy that produces uniform presynaptic neuropeptide stores. 
This chapter was largely written and edited by my advisor Dr. Edwin Levitan in the 
format of a research article. It has been published as “Neuropeptide delivery to synapses by long-
range vesicle circulation and sporadic capture” in Cell in March 2012 (Wong et al., 2012). All 
the experimental design, data collection and data quantification were performed by me with 
advice from Dr. Dinara Shakiryanova. It also has contribution by Drs. Chaoming Zhou, David 
Deitcher and Thomas Lloyd for the generation of genetic mutants that were used in many 
experiments.  
2.3 RESULTS 
2.3.1 Preferential anterograde transport of DCVs to the most distal bouton 
To determine how the uniform neuropeptide stores in Drosophila motoneuron type Ib boutons 
(Anderson et al., 1988a) are supplied, the Geneswitch (GS) system (Nicholson et al., 2008) was 
used to induce expression of Emerald GFP-tagged Atrial Natriuretic Factor (Anf-GFP), a 
reporter of native neuropeptide packaging and release in Drosophila larvae (Heifetz and 
Wolfner, 2004; Husain and Ewer, 2004; Kula et al., 2006; Loveall and Deitcher, 2010; Rao et al., 
2001b; Shakiryanova et al., 2006a).  Independent of Anf-GFP labeling, boutons were detected 
with a TRITC-conjugated anti-horseradish peroxidase antibody (TRITC-HRP) and numbered 
from distal to proximal (Figure 7A).  Surprisingly, neuropeptide accumulated initially in the 
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most distal bouton (#1) and only later was distributed uniformly among en passant boutons #1-4 
(Figure 7A,B).  Similar results were obtained with heat shock induction of GFP-tagged 
Drosophila proinsulin-like peptide 2 (Dilp2-GFP, Figure 7C,D).  Therefore, the initial distal 
accumulation cannot be attributed to a particular neuropeptide or induction mechanism.  Finally, 
when neuropeptide release was inhibited by removing extracellular Ca
2+
, fluorescence recovery 
after photobleaching (FRAP) of constitutively expressed Anf-GFP (i.e., driven by elav-GAL4) 
also revealed preferential neuropeptide accumulation in the most distal bouton (Figure 7E,F, 
Movie S1).  This finding independently verifies the polarized neuropeptide accumulation 
detected with pulse labeling and furthermore proves that this pattern cannot be explained by 
differential release by en passant boutons. 
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Figure 7 Neuropeptide accumulates initially in the most distal bouton 
A. Nerve terminal Anf-GFP fluorescence images after RU486 induction for 5 and 100 hours. TRITC-conjugated 
HRP labeling localized the neuronal membrane. En passant boutons are numbered from the most distal (#1) to 
proximal (Scale bar, 5 µm). B. Quantification of fluorescence relative to the most distal bouton (%F) after RU486 (5 
h, n=11; 20 h, n=10; 100 h, n=12).  Note that data are displayed from most distal bouton #1 to proximal bouton #4. 
C. Nerve terminal Dilp2-GFP images after heat shock induction for 5 or 24 hours. Scale bar, 5 µm.  D. 
Quantification of Dilp2-GFP fluorescence after heat shock induction for 5 h (n=8) and 24 h, n=5). Note that data are 
displayed from most distal bouton #1 to proximal bouton #4. E. Time-lapse images before and after photobleaching 
(Scale bar, 2.5 µm).  Contrast was adjusted to visualize DCV puncta. F. FRAP quantified in the most distal bouton 
(#1) and a proximal bouton (#4) (n=12). In all figures, error bars are standard error of the mean.  See also Movie S1. 
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The above experiments exclude many potential models for maintaining neuropeptide 
stores in en passant boutons including delivery in order, stochastic delivery and parallel address-
based delivery.  Instead, there must be a routing mechanism that preferentially produces DCV 
accumulation in the most distal bouton at first, but eventually results in evenly distributed DCVs.  
To gain insight into this mechanism, DCVs were tracked as they populated the nerve terminal 
with a new approach called simultaneous photobleaching and imaging (SPAIM).  In initial 
SPAIM experiments the distal region of the nerve terminal was photobleached.  Then after a 
punctum likely corresponding to a single DCV (Shakiryanova et al., 2006a) entered the 
photobleached region, a laser beam was positioned to photobleach subsequent newcomers.  
Finally, while continually photobleaching newcomers, a second independent scanning beam was 
used to simultaneously image the unbleached DCV for minutes (Figure 8A).  This allowed the 
initial unbleached bright DCV to be distinguished from the nearly completely photobleached 
newcomers (Movie S2).   
 SPAIM revealed complex anterograde DCV routing within the nerve terminal.  For 
example, an individual trajectory from a proximal bouton to the most distal bouton contained 
multiple pauses, a transient change in direction and looping exploration of boutons before 
coming to rest (Figure 8B, Movie S2).  Bouton visits fell into 3 kinetic classes:  (1) DCVs 
moving 0.75 ± 0.03 µm/s (n=62) bypassed a bouton within 5 s in 45% of cases, (2) visited 
boutons transiently (5-120 s) or (3) stayed longer than 5-10 minute time-lapse experiments 
(Figure 8C,D), which were classified as capture.  Because proximal capture was infrequent 
(Figure 8D, open bars), anterograde flux dropped at each proximal bouton by ~10% (Figure 8E).  
This result has two implications:  first, there is nearly uniform accumulation of anterograde 
DCVs in each proximal bouton because there is modest depletion of DCV flux at each bouton, 
 34 
and second, capture in proximal boutons is inefficient so that excess DCVs remain to accumulate 
in the most distal bouton (Figure 8D filled bars, E).  These experiments show that DCVs do not 
move directly to their ultimate destinations, but instead can pause and make detours along the 
way.  Furthermore, the initially polarized accumulation of neuropeptide is caused by the sporadic 
proximal capture of anterograde DCVs as they make their complex journey through the terminal. 
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Figure 8 Complex anterograde DCV traffic in the terminal   
A. SPAIM experimental design. Blue boxes, photobleaching regions; Red arrow, possible trajectory of the 
newcomer DCV.  At least 4 boutons were examined in each experiment. B. Anterograde DCV images (upper and 
middle) and trajectory (bottom). Red, anterograde; Blue, retrograde. Colored numbers indicate pause durations in 
seconds. Scale bar, 5 µm. C. Frequency distribution of visits >5 s (n= 138 from 62 tracked DCVs in 17 animals, 30 s 
binning) at en passant boutons, which comprise 55% of total events.  Dashed line indicates events that were 
interrupted by the end of time-lapse data acquisition.  D. Probability of DCVs to bypass (duration 0-5 s), transiently 
visit (duration 5-120 s) or be captured (duration >120 s) at boutons #1 and #4 (n=86 events from 14 DCVs in 14 
animals).  E.  Anterograde DCV flux between boutons in 5 minutes after photobleaching (n=15).  See also Movie 
S2. 
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2.3.2 Retrograde DCV transport delivers neuropeptide to proximal boutons 
Given that anterograde transport is biased to the most distal bouton, how is uniform neuropeptide 
storage eventually accomplished?  The above SPAIM experiments showed that changes in 
transport direction were rare and transient in proximal boutons.  However, in 10 of 62 initially 
anterograde trajectories acquired, DCVs converted to retrograde transport in the most distal 
bouton.  Analysis of these events showed that their number was limited because conversion to 
retrograde transport was slow (i.e. comparable to the time scale of these experiments).  Thus, 
retrograde flux had not yet reached values found at steady state.  Nevertheless, this result raised 
two new questions.  First, if newcomer anterograde DCVs can leave the distal bouton, might 
retrograde transport dissipate the initial distal gradient in neuropeptide accumulation?  Second, 
what is the fate of DCVs that leave the distal bouton by retrograde transport? 
 To address these questions, SPAIM experiments were designed to detect retrograde 
traffic of DCVs that had already accumulated in the most distal bouton.  In this case, proximal 
boutons were photobleached, but the most distal bouton was spared.  Then anterograde 
newcomers were continually photobleached by a laser beam located upstream of the region of 
interest while simultaneously imaging DCVs leaving the most distal bouton with the second 
scanner (Figure 9A top).  For comparison, SPAIM was also used to detect traffic out of a 
proximal bouton (Figure 9A bottom).  These experiments showed that retrograde DCV flux from 
the distal bouton was far greater than DCV flux from a proximal bouton (Figure 9B, Movie S3 
and Movie S4), suggesting that retrograde DCV transport out of the most distal bouton removes 
excess DCVs supplied by anterograde transport. 
 Consistent with this conclusion, inhibition of retrograde transport resulted in excess 
neuropeptide accumulation in the most distal bouton.  Because retrograde transport depends on 
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activation of the motor dynein by the dynactin multisubunit complex, it can be inhibited by 
genetically affecting dynactin subunits (e.g. by driving expression of dominant negative p150 
Glued (Gl
Δ96
) (Allen et al., 1999) or dynamitin (Dmn) overexpression (Burkhardt et al., 1997)).  
Transgenic expression of Gl
Δ96
 or Dmn resulted in excess Anf-GFP accumulation in the most 
distal bouton (Figure 9C, D).  The effect of inhibiting retrograde transport was not limited to 
Anf-GFP because, in the absence of any GFP construct expression, Gl
Δ96
 also promoted distal 
accumulation of the native neuropeptide proproctolin (Figure 9E, F).  Therefore, dynactin-
dependent retrograde DCV transport is required to dissipate the neuropeptide gradient produced 
by anterograde transport. 
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Figure 9 Retrograde transport of excess DCVs out of the distal bouton 
A.  SPAIM strategies for detecting DCV efflux from distal (Top) and proximal (bottom) boutons in 5 minutes 
after photobleaching large blue rectangles. The green boutons were spared from photobleaching and then anterograde 
newcomers were blocked by the beam positioned at the location of the small blue squares. Flux was measured at the 
position of the arrows (Red, anterograde; Blue, retrograde).  B. Quantification of DCV flux from proximal (n=10) and 
distal (n=13) boutons. C. Pseudo-color images showing distal Anf-GFP accumulation after inhibiting dynactin with Gl
Δ96
 
or Dmn. Scale bar, 5 µm. Warmer colors represent higher fluorescence. D. Anf-GFP intensity relative to the wild type 
control (WT) distal bouton (%F) (WT, n=18; Gl
∆96
, n=20; Dmn, n=7). See also Figure S1 and Movies S3 and S4. E. 
Immunofluorescence signal for proproctolin in muscle 4 boutons of wild type (WT) and Gl 96 animals.  Bar, 5 m. F. 
Quantification of proproctolin fluorescence levels in en passant boutons (n=7). 
E 
 
F 
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 Interestingly, SPAIM showed that retrograde transport in the terminal shares many 
features found with anterograde transport.  First, retrograde DCVs moving 0.73 ± 0.03 µm/s 
(n=63) often (i.e. 56% of events) bypassed proximal boutons (Figure 10A).  Second, trajectories 
featured both transient visits and capture in proximal boutons, as well as rare transient reversals 
in direction (Figure 10A, B).  Third, capture was inefficient and uniform among proximal 
boutons so that flux dropped by ~10% per bouton (Figure 10C).  This similarity to anterograde 
capture ensures that any subtle proximal-distal gradient produced on the way toward the distal 
bouton is counterbalanced by a symmetric gradient in capture on way back from the distal 
bouton.  Most importantly, inefficient sporadic capture of retrograde DCVs contributes to 
neuropeptide accumulation in proximal boutons. 
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Figure 10 Retrograde DCV traffic and capture in the terminal 
A. Top two panels, SPAIM strategy for detecting retrograde DCVs leaving the most distal bouton. Third panel, 
image of boutons prior to photobleaching.  Bottom three panels, sample retrograde trajectories.  The first shows 
transient visits and an anterograde reversal.  The second shows capture.  The third shows bypasses to exit region of 
interest. Blue, retrograde; Red, anterograde; Overlapping anterograde and retrograde, black; Scale bar, 5 µm. B. 
Frequency distribution of retrograde visits >5 s (n=106 events in 63 tracked DCVs in 20 animals), which comprise 
57% of total events. Dashed line indicates events that were interrupted by the end of time-lapse data acquisition. C. 
Retrograde flux of DCVs from bouton #1 in 5 minutes after photobleaching (n=7).  
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2.3.3 Uncaptured retrograde DCVs stop just before reentering the soma 
Another consequence of inefficient capture was that some retrograde DCVs were not captured in 
any of the proximal boutons.  Because Drosophila motoneuron terminals are branched structures 
(Figure 11A), retrograde DCVs must therefore either change direction to reenter the same or a 
neighboring terminal branch or continue on into the axon (Figure 11B).  SPAIM was used to 
distinguish between these possibilities:  after photobleaching a branch point, retrograde traffic 
was imaged while simultaneously photobleaching anterograde newcomers (Figure 11C).  Time-
lapse imaging showed that retrograde DCVs never turned to enter another terminal branch, only 
rarely reversed direction to return to the same branch and usually continued on into the axon 
(Figure 11D, Movie S5).  Therefore, uncaptured retrograde DCVs are not typically retained in 
the terminal, but instead proceed toward the soma. 
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Figure 11 Uncaptured retrograde DCVs leave the terminal to enter the axon 
A. Projection stack showing Anf-GFP in a muscle 4 terminal with photobleached branch point indicated with a box. 
Scale bar, 10 µm. B. Single image of the photobleached region showing DCVs and possible retrograde trajectories 
(colored arrows). Scale bar, 2.5 µm. C.  SPAIM strategy for viewing retrograde DCVs entering branch point.  
Following photobleaching of the branch point (large blue box), anterograde newcomers are photobleached (small 
blue box) while simultaneously imaging retrograde DCVs.  D.  Quantification of retrograde DCV flux at the branch 
point (n=7).  Note that the preferential traffic into the axon was also seen at muscle 6/7 terminals.  See also Movie 
S5. 
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There is extensive retrograde transport of neuropeptidergic DCVs in the axon (Alonso 
and Assenmacher, 1983).  A conventional hypothesis would be that retrograde DCVs return to 
the soma to be degraded.  However, SPAIM demonstrated that many DCVs contribute to 
retrograde transport simply because they were not captured on the way to and from the most 
distal bouton.  Therefore, transport back through the proximal axon into the soma was imaged to 
determine the fate of retrograde DCVs.  Unfortunately, resolving this traffic in motoneurons was 
not feasible for three reasons.  First, the soma and axon are often not in a single plane of focus, 
which is needed for continual imaging of transport.  Second, available motoneuron drivers label 
multiple clustered somata, which makes it difficult to discriminate individual axon-soma pairs.  
Finally, because motoneuron somata are located in the central nervous system (i.e. the ventral 
ganglion), light scattering by the surrounding tissue degrades the confocal signal from individual 
DCVs and interferes with photobleaching.  Because of these limitations, retrograde DCV traffic 
was studied in an optically accessible neuron that is amenable to imaging traffic back through the 
proximal axon to the soma. 
 Specifically, we focused on the lateral td neuron, which has its soma located on the 
surface of the body wall near muscle 8 and produces an anterior projecting dendrite and a 
posterior projecting axon (Bodmer, 1987).  In the larva, the lateral td neuron expresses Anf-GFP 
in response to the peptidergic cell driver 386A-GAL4 (Figure 12A).  Importantly, the soma, 
proximal processes and the first axonal branch of lateral td neurons can be imaged in a single 
plane of focus (Figure 12A).  Little DCV traffic entered the proximal dendrite, as expected for a 
presynaptic cargo (Rolls, 2011).  Therefore, we determined the fate of retrograde DCVs moving 
from the segmental nerve and peripheral axons toward the td neuron soma, which is 
distinguished from the proximal axon by morphology and the reciprocal distributions of the 
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microtubule associated protein futsch and the Golgi marker mannosidase II-egfp (ManII-GFP; 
(Ye et al., 2007) (Figure 12B).  Surprisingly, in 5 minute FRAP experiments, retrograde DCVs 
accumulated in the proximal axon (i.e. the region between the soma and the first axonal branch) 
far more than in the soma (Figure 12C, Movie S6).  Time-lapse experiments showed that this 
occurred because flux into the soma was ~7.5-fold less than into the proximal axon (Figure 
12D).  Thus, only a small fraction of retrograde DCVs traverse the proximal axon to enter the 
soma. 
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Figure 12 Accumulation of retrograde DCVs in the proximal axon 
A. Anf-GFP (Top) expressed in a lateral td neuron.  Neuronal membrane was labeled with TRITC-HRP 
antibody.  Scale bar, 10 µm. B. Localization of the Golgi marker (Man II-GFP, green) and the microtubule 
associated protein futsch detected by immunofluorescence (blue). Scale bar, 5 µm.  C.  Representative images of the 
lateral  td neuron soma and proximal axon before and after photobleaching. Scale bar, 5 µm. D. Quantification of 
retrograde DCV flux into the proximal axon and soma (n=10).  See also Movie S6. 
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2.3.4 Retrograde DCVs circulate back into the axon 
Three independent lines of experimentation demonstrated that DCVs switch from retrograde to 
anterograde transport in the proximal axon.  First, the soma and proximal axon were 
photobleached.  SPAIM was then used to detect nascent anterograde DCVs in the absence of 
retrograde newcomers.   As expected, the flux of nascent DCVs, which originated only from the 
soma, was very low in the 5 minutes after photobleaching (Figure 13A, Soma, B).  Yet, 
anterograde flux out of the proximal axon measured in this time period was easily detected when 
retrograde DCVs were not photobleached (Figure 13A, proximal axon open bar, Movie S6).  
Therefore, anterograde DCVs exiting the proximal axon must have been former retrograde 
newcomers.  Second, the effect of photobleaching retrograde newcomers from the axon on 
anterograde flux out of the proximal axon was determined.  When the supply of retrograde DCVs 
from the axon was cut off, anterograde exit of DCVs from the proximal axon was nearly 
eliminated (Figure 13A, proximal axon open and filled bars).  Again, this result is consistent with 
reversal of retrograde DCVs in the proximal axon.  Finally, in 5 minute trajectories detected by 
SPAIM (Figure 13C), ~30% of retrograde DCVs reversed and left the proximal axon by 
anterograde transport (Figure 13D, Movie S7).  In contrast, reversals in the soma only occurred 
in ~2% of trajectories, showing that the proximal axon is the major turnaround site for retrograde 
DCVs.  Interestingly, after converting to anterograde transport, DCVs left either by the branch 
they used to approach the soma or the other possible axonal branch.  Therefore, retrograde 
axonal transport provides DCVs that circulate back from the proximal axon to generate 
anterograde transport toward all release sites, where DCVs can be captured while traveling to 
and from the most distal boutons. 
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Figure 13 Retrograde DCVs reverse in the proximal axon to reenter the axon 
A.  Anterograde flux from the proximal axon and soma in 5 minutes after photobleaching.  +SPAIM indicates that 
retrograde newcomers were photobleached.  B.  SPAIM experimental design to prevent retrograde newcomers from 
the axon entering the large photobleached region so flux from nascent DCVs moving out of the soma (red arrow) 
can be quantified.  C.  SPAIM experimental design to determine trajectories of retrograde DCVs entering the 
proximal axon.  Note that photobleaching of retrograde newcomers began only after a one DCV entered the 
proximal axon from the axon.  D. 5 minute trajectories of retrograde DCVs after returning to the proximal axon.  
Left images describe trajectory classes.  Right images show representative data. Percentage of tracked DCVs (n=54) 
for each class is presented on the right. Blue lines, retrograde; Red lines, anterograde. 
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2.4 DISCUSSION 
2.4.1 Supplying en passant boutons by vesicle circulation  
One-way anterograde transport of DCVs was believed to fully explain neuropeptide delivery to 
nerve terminals.  However, SPAIM in different neuronal compartments (i.e. en passant boutons, 
axonal branches, the proximal axon, and the soma) showed that neuropeptide accumulation in 
nerve terminal release sites is mediated by sporadic anterograde and retrograde capture of DCVs 
circulating between the proximal axon and distal boutons (Figure 14).  These findings cannot be 
attributed to phototoxicity as they are supported by SPAIM-independent induction and mutant 
experiments, the match between flux measured without photobleaching (Shakiryanova et al., 
2006a), the consistency of DCV behavior after multiple bouts of photobleaching, and the 
detection of release from single DCVs (See Chapter 4), which demonstrates viability and 
function.   
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Figure 14 Vesicle circulation model for synaptic neuropeptide delivery 
Vesicle circulation model for synaptic neuropeptide delivery.  Anterograde DCVs are routed from the soma toward 
the most distal bouton in each branch.  After reversing, dynactin-mediated retrograde transport routes DCVs past 
branch points into the axon.  Once arriving in the proximal axon, many retrograde DCVs reverse to journey toward 
release sites again, thus avoiding degradation in the soma.  While undergoing long-distance circulation, there is a 
low probability of being captured at each proximal bouton.  This produces initial accumulation in the most distal 
bouton.  However, because capture is slow compared to vesicle flux, neuropeptide stores in en passant boutons 
eventually fill equally despite differences in distance from the soma.  See also Movies S6 and S7. 
 
It was surprising that DCVs travel such far distances and that their presynaptic capture is 
inefficient, but this elegantly overcomes the limitations of relying solely on one-way transport 
(see Introduction) to produce the uniform neuropeptide accumulation that characterizes en 
passant boutons. Indeed, the conundrum of how to ensure that all potential release sites can 
function effectively regardless of distance from the soma or presence on different branches, 
which is critical for neurons, is resolved by vesicle circulation.  Vesicle circulation also accounts 
for the long known, but mysterious, abundance of retrograde DCVs in axons (Alonso and 
Assenmacher, 1983) and ensures that DCVs do not readily return to the soma to be degraded.  
Furthermore, vesicle circulation provides a novel explanation for the finding that perturbing 
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retrograde DCV transport in neurons affects anterograde transport (Kwinter et al., 2009):  
interrupting retrograde transport prevents circulating retrograde DCVs from contributing to 
anterograde flux and so would reduce total anterograde transport.  Finally, because the same 
kinesin motor transports neuropeptides and many other presynaptic proteins (Barkus et al., 2008; 
Hall and Hedgecock, 1991; Jacob and Kaplan, 2003; Okada et al., 1995; Pack-Chung et al., 
2007a), vesicle circulation could be a general strategy for maintaining the synaptic function of en 
passant boutons. In this light, it is interesting that retrograde transport is compromised in 
neurodegenerative diseases (Strom et al., 2008); (Perlson et al., 2010). A previously 
unconsidered contributing factor to the early onset loss of synaptic function could be that 
diseases that affect dynactin-dependent retrograde transport perturb vesicle circulation that 
normally maintains the terminal.   Therefore, vesicle circulation may be significant under 
physiological and pathological conditions. 
2.4.2 SPAIM:  a new tool for studying traffic 
SPAIM detects DCVs in a native synapse for many minutes.  In contrast, we found that 
photoactivation-based approaches using PA-GFP, tdEosFP and mOrange did not work well with 
Drosophila DCVs.  This may be due to suboptimal targeting, difficulty in inducing 
photoactivation in the mildly acidic (Sturman et al., 2006) and oxidizing lumen of Drosophila 
DCVs, and the lower brightness and poorer folding of many photoactivatable proteins compared 
to emerald GFP.  Given the availability of bright, well characterized GFP constructs, SPAIM 
represents a tenable method for tracking DCVs in native Drosophila neurons.  In addition to 
detecting vesicle circulation, SPAIM could be used to study how presynaptic DCV mobilization 
is induced by activity in a native synapse and how DCV traffic changes with synaptic 
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development and plasticity.  Furthermore, as noted above, SPAIM can detect release from single 
DCVs induced by nerve stimulation, which opens the possibility of studying peptidergic 
transmission at the level of individual vesicles in a native synapse.  Therefore, SPAIM could 
answer many questions concerning neuronal DCVs. 
 In principle, SPAIM could be applied to any fluorescent organelle.  However, a dual 
scanner confocal microscope, which was used here, might not be ideal for detecting very dim 
signals.  When optical sectioning is not required, this limitation could be overcome by using a 
single scanner system for initially photobleaching a region of interest and then for continually 
photobleaching newcomers while simultaneously imaging individual organelles with a sensitive 
camera.  In fact, performing SPAIM experiments by coupling a camera with a common single 
scanner confocal microscope may be an attractive option to overcome both the insensitivity and 
the expense of dual scanner systems.  With the appropriate setup, SPAIM could be used to study 
traffic in terminals, dendrites, cilia, and filopodia. 
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2.5 MATERIALS AND METHDOS  
2.5.1 Drosophila 
Emerald GFP was inserted at the EcoRV cut site in the preproDilp2 C-peptide sequence (kindly 
provided by E. Rulifson) and the resultant Dilp2-GFP fragment was cloned into the pUAST 
vector at the EcoRI and NotI sites for generation of transgenic UAS-Dilp2-GFP/CyO flies. 
 The following lines were maintained as double homozygotes for both transgenes, with 
female larvae selected for imaging experiments: elav>Anf-GFP (elav-Gal4C155 UAS-
preproAnf-EMD), 386A>Anf-GFP (w, UAS-preproAnf-EMD;386A-Gal4), HS>Dilp2-GFP (w; 
UAS-Dilp2-GFP/CyO; Hsp70-Gal4) and GS>Anf-GFP (GS 3550-2, UAS-preproAnf-EMD).  To 
study the role of dynactin, male wild type (Canton S), UAS-Gl∆96 and UAS-Dmn flies were 
crossed with female GS>Anf-GFP flies and F1 male larvae were selected for imaging.  To 
localize the Golgi in lateral td neurons, UAS-ManII-GFP (Ye et al., 2007; kindly provided by 
Y.N. Jan) males were crossed with female 386A-Gal4 flies and F1 larvae were used for imaging.  
 All animals were raised at 25
o
C, except in heat shock induction experiments in which 
larvae grown at 18
o
C were incubated at 37
o
C for 2 h and then maintained at 29
o
C.   For RU486 
induction, GS>Anf-GFP larvae were transferred to food containing 100 µg/ml RU486, which 
was made from a stock ethanol solution containing 100 mg/ml RU486 (Mifepristone; Sigma) 
mixed into freshly cooked Jazzmix food (Fisher Scientific) that had been cooled down to 60
o
C.  
In induction experiments, 3
rd
 instar larvae, selected at specific time points after heat shock or 
RU486 exposure, were filleted and incubated with TRITC-conjugated anti-HRP (1:100, Jackson 
Immunoresearch) for 20-30 minutes on ice to stain neuronal membranes prior to GFP imaging. 
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2.5.2 Immunocytochemistry and Antibodies 
Filleted larvae were fixed in 4% parfomaldehyde with 7% picric acid for 1 hour followed by 
permeabilization with 0.3% Triton X-100.  For futsch labeling, the following antibodies were 
used: anti-Futsch/22C10 (1:100, Developmental Studies Hybridoma Bank) and Alexa 350- 
conjugated goat anti-mouse IgG (1:1000, Invitrogen). For proctolin precursor labeling, 
preparations were incubated in polyclonal anti-proctolin precursor serum (1:1000; Taylor et al., 
2004; kindly provided by D.R. Nässel) at 4
o
C for 2 days followed by Dylight 488-conjugated 
goat anti-rabbit IgG (1:1000, Jackson Immunoresearch). 
 
2.5.3 Imaging   
Transport was quantified in muscle 6/7 type Ib boutons, muscle 4 motoneuron branches 
(although consistent results were obtained in muscle 6/7 branches) and lateral td neurons.  In all 
cases, wandering 3rd instar larvae were filleted and imaged (Levitan et al., 2007) in Ca
2+
-free 
HL3 solution (in mM:  70 NaCl, 5 KCl, 0.5 Na3EGTA, 20 MgCl2, 10 NaHCO3, 5 trehalose, 115 
sucrose, and 5 HEPES, pH 7.2) with an upright Olympus Fluoview FV1000 confocal laser 
scanning microscope equipped with an 80/20 beamsplitter in the laser combiner, a second “SIM” 
scanner, a dichroic mirror to recombine the SIM and main scanner beams, and a Olympus 
LUMFL 60X (NA 1.1) water immersion objective. GFP and TRITC were imaged using 488 nm 
and 559 nm excitation lasers, respectively.  All prebleached images and images taken for 
quantification purpose were acquired at a minimum resolution 17 pixels/µm at laser power and 
detection settings that did not generate saturated signals or produce significant photobleaching.  
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When time-lapse was not required, fluorescence intensity for each en passant bouton was 
measured in Z stacks (29 images at 0.35 µm steps) taken of type Ib terminals on muscle 6/7.  For 
td neurons, single images were acquired, with the trachea left intact.  Photobleaching was 
performed using 100% 488 nm laser power from the SIM scanner in the line scanning mode.  
Time-lapse images were taken at 1 frame/s at a single plane of focus. To enable detection of 
single DCVs in flux and tracking experiments, time-lapse images were taken with a 5-fold 
increase in 488 nm main scanning laser power compared to prebleach images. 
 In SPAIM experiments, initial photobleaching was performed using 488 nm SIM 
scanning at speed of 40-100 m/pixel and 100% SIM laser power.  Then the SIM scanner setting 
was reduced to 20%-30% power (i.e., 110 µW below the objective) for simultaneous 
photobleaching while acquiring images with the main scanner using ~4 µW of power below the 
objective scanning at 4 m/pixel.  All SPAIM experiments lasted at least 5 minutes or until the 
DCV reversed direction and left the region of interest in tracking experiments.  
2.5.4 Image Analysis 
Images were analyzed using ImageJ (NIH) software. For intensity measurements, stacks were 
first transformed into averaged Z projections. A region of interest was drawn around each bouton 
and background subtracted GFP fluorescence was measured as the mean grey value unless 
otherwise specified. In pulse-labeling experiments, boutons were identified with HRP labeling. 
FRAP (∆%Fo) of each bouton was calculated as relative fluorescence to the corresponding 
prebleached bouton subtracted by the residual fluorescence immediately after photobleaching. In 
dynactin perturbation experiments, fluorescence was measured as total grey value from the 
averaged Z projection. Flux was determined by manually counting DCVs moving through a ROI 
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over a period of minutes. Single DCVs were tracked and trajectories were plotted using the 
Manual Tracking plugin in ImageJ.  
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3.0  CHARACTERIZATION OF DCV EXOCYTOSIS AT NERVE TERMINALS 
3.1 ABSTRACT 
Neuropeptides, which control emotion, behavior and body homeostasis, are released at nerve 
terminals through the exocytosis of dense-core vesicles (DCVs). Because the neuropeptide store 
at nerve terminals relies exclusively on the supply of nascent DCVs from the distant soma, tight 
regulation of neuropeptide release should be ensured to prevent the deprivation of releasable 
DCVs after activity. Although DCV exocytosis has been extensively studied, most findings were 
based on endocrine cell cultures that lack special polarized and differentiated features of neurons. 
Here, we use simultaneous photobleaching and imaging (SPAIM) to study exocytosis of single 
DCVs in vivo at the Drosophila larval neuromuscular junction (NMJ). Results show that release-
competent DCVs supply neuropeptides to the terminal constantly, independent of their transport 
direction, location and mobility.  These DCVs release exclusively by kiss-and-run exocytosis, 
and neuropeptides are dissipated slowly. More interestingly, these partially emptied DCVs can 
undergo multiple rounds of exocytosis to further discharge their contents. Overall, the study 
suggests that terminals are supported by the constant supply and recycling of releasable DCVs. 
At the same time, neuropeptide stores are utilized only progressively through partial release, thus 
preventing the deprivation of resources during repetitive firing. 
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3.2 INTRODUCTION 
After neuropeptides are synthesized and packaged at the soma, neuropeptide-containing DCVs 
are delivered to release sites, where they await action potentials to trigger exocytosis. Because 
neuropeptides cannot be synthesized at the periphery or recycled after release, efficient 
neuropeptide transmission relies on the supply of DCVs from the soma. Of equal importance, the 
amount of release must be tightly controlled to prevent deprivation of neuropeptides at the 
terminal. Despite the abundance of DCVs at the terminal, only a small fraction of them are 
capable to undergo exocytosis. It is now believed that releasability of DCVs is associated with 
multiple biophysical properties. 
Releasability depends on the mobility and age of DCVs. Direct imaging in differentiated 
PC12 cells and hippocampal neurons revealed that a fraction of DCVs are highly mobile. Unlike 
small synaptic vesicles (SSVs), DCVs do not need to be immobilized closed to the plasma 
membrane before exocytosis. Instead, exocytosis is favored by membrane-distal DCVs that 
move towards the plasma membrane upon stimulation (Han et al., 1999; Ng et al., 2003; 
Silverman et al., 2005). Indeed, mobility of DCVs promotes DCV releasability. First, DCV 
mobility is correlated with fusion probability, and that molecular-scale motion is required before 
fusion (Degtyar et al., 2007). In addition, it was found that activity-dependent mobilization of 
DCVs facilitates post-tetanic potentiation (PTP) of neuropeptide release (Shakiryanova et al., 
2005).  Releasability is also favored by younger vesicles. With the use of timer fluorescent 
proteins, such as DsRedE5 and monomeric Kusabira Green Orange (mK-GO), DCVs were 
labeled with different colors depending on their age. It was found that younger vesicles undergo 
exocytosis more frequently (Duncan et al., 2003; Tsuboi et al., 2010; Wiegand et al., 2003). 
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Releasable DCVs may fully collapse into the plasma membrane after exocytosis, 
discharging all their neuropeptides at once. The vesicle membrane is then recycled by clathrin-
dependent endocytosis.  More frequently, they undergo kiss-and-run exocytosis, in which DCVs 
are fused only transiently with the plasma membrane, and neuropeptides are released partially 
through the fusion pore before DCVs are rapidly endocytosed. The transient fusion pore 
formation limits the time and extent of neuropeptide release during exocytosis. At the same time, 
both the size and biochemical properties of the neuropeptide contribute to its diffusion rate.  
DCV exocytosis was classically studied by membrane capacitance and amperomery 
measurements. Thus far, the most popular experimental model has been endocrine cell culture 
(e.g. chromaffin and PC12 cells). Because neuronal processes or well-differentiated nerve 
terminals are absent in these models, no information can be obtained about exocytosis properties 
of DCVs in relation to their specific transport direction and bouton location. Even with the use of 
the neuronal culture, such as developing hippocampal neurons, synaptic boutons are too small to 
resolve the movement of DCVs. In addition, in vitro models are always less desirable systems 
because they may not reflect the true property of neurons that have a post-synaptic partner. 
Here, we use the Drosophila larval neuromuscular junction (NMJ) as an in vivo model to 
study DCV exocytosis at the nerve terminal. By labeling DCVs with GFP-tagged neuropeptides, 
together with the use of a newly developed imaging strategy, simultaneous photobleaching and 
imaging (SPAIM), the movement and exocytosis of individual DCVs within en passant boutons 
are imaged upon electrical stimulation. Specifically, we address whether DCVs are more 
releasable when they are 1) captured in the anterograde or retrograde directions; 2) captured at a 
particular en passant bouton location; 3) captured or just transiently visiting the bouton; 4) 
mobile or immobile. We also examine the release kinetics of neuropeptides from single DCVs 
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during exocytosis. Results show that release-competent DCVs supply neuropeptides to the 
terminal constantly, independent of their transport direction, location and mobility.  These DCVs 
release exclusively by kiss-and-run exocytosis, and neuropeptides are released slowly. More 
interestingly, these partially emptied DCVs can undergo multiple rounds of exocytosis to further 
discharge their contents. 
3.3 RESULTS 
3.3.1 Single DCVs exocytosis at the nerve terminal by SPAIM tracking  
Electrical stimulation (1 min 70 Hz) was applied while single DCVs labeled with GFP tagged-
atrial natriuretic factor (Anf-GFP) were tracked in the nerve terminal by SPAIM (see Chapter 2 
for detailed description of the method). Upon stimulation, fluorescence decreases were seen in 
some of these DCVs, suggesting neuropeptide release (Figure 15A, B). To ensure that the 
fluorescence decrease is Ca
2+
 influx-dependent, SPAIM experiments were performed under 
Ca
2+
-free conditions. Here, the acute release of neuropeptide during stimulation was abolished, 
although a slow and small fluorescence decrease (~15-20%) was seen 30 s after the onset of 
action potentials (Figure 15C), suggesting that a small portion of neuropeptides may be released 
through a Na
+
-dependent, Ca
2+
 influx-independent pathway. Releasable and unreleasable DCVs 
were sorted based on the amount of neuropeptide release after 1 min stimulation: the frequency 
distribution in Figure 15D shows two distinct populations of releasable vesicles. One of these,  
with about 70% DCVs, released more than 18% neuropeptide content, and represents the Ca
2+
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releasable pool. The population with less release represents Ca
2+ 
influx-independent events and 
are classified as unreleasable for our study (Figure 15D).              
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Figure 15 Measuring neuropeptide release from single DCVs by SPAIM 
A. Representative pseudocolored time-course images of a releasable (Top), and an unreleasable (Bottom) single 
DCV before and after 1 min 70 Hz stimulation. Scale bar= 2μm. B. Representative neuropeptide release time course 
of a releasable and an unreleasable DCV. Neuropeptide release was quantified as the percentage change of 
percentage fluorescence prior to stimulation (%F). C. Average time course of neuropeptide release from DCVs 
stimulated in Ca2+ free medium. Note the delay neuropeptide release after 30s. D. Frequency distribution of 
neuropeptide release from all the DCVs under study (n=39). Here, neuropeptide release was calculated by averaging 
Δ%F from t=60- 120s after stimulation, when release has usually plateaued. Error bars represent SEM.  
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3.3.2 Releasability of DCVs as measured by probability and size of release 
As described previously, newly arrived DCVs from either the anterograde or retrograde direction 
can bypass boutons quickly (<5 s), stay inside a bouton for a transient visit (5-120 s), or be 
captured for a prolonged period (>120 s) (see Chapter 2).  To test if directionality and capture 
affect release probability, electrical stimulation was applied while DCVs were visiting transiently 
or captured in a bouton. In these experiments, captured DCVs were defined as those that stayed 
within the same bouton for at least 2 mins before stimulation, while visiting DCVs were defined 
as those that stayed within the same bouton for less than 1 min.  (Figure 16A, top).  Anterograde 
or retrograde DCVs that were captured or visiting a bouton also underwent exocytosis with 
similar probability (50-75%) (Figure 16A, Bottom). Although trajectories of DCVs show that 
DCVs may stay immobile, jitter, or loop around a bouton during visits or captures (Figure 16B, 
top, also see Chapter 2), the mobility preceding activity did not affect releasability (Figure 16B, 
Bottom). Finally, release probabilities of DCVs was also independent of their respective bouton 
location (Figure 16C).  
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Figure 16 Releasability of DCVs in relation to their transport directions, time of residence, mobility and 
bouton locations 
A. Top panel: Upon arrival at a bouton from either direction, DCVs may visit transiently or be captured (See 
Chapter 2). DCVs were induced to undergo exocytosis after specific time periods as shown. Bottom: Exocytosis 
probability of anterograde and retrograde DCVs that were visiting or captured (Anterograde visit, n=6 Anterograde 
capture, n=17; Retrograde visit, n=7; Retrograde capture, n=9) B. Top panel: Possible trajectories of DCVs when 
visiting or captured in the respective bouton.  Bottom: Probability of exocytosis after DCVs have displayed specific 
behavior (Immobile, n=25; Jittering, n=12; Looping, n=2). C. Top panel: En passant bouton location with specific 
numbering. Bottom: Probability of exocytosis at different bouton locations (Bouton 1, n=8; Bouton 2, n=14; Bouton 
3, n=11; Bouton 4, n=6) 
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 To further examine releasability, we also monitored the time course and extent of 
neuropeptide release from releasable DCVs. DCVs captured at either the proximal or distal 
boutons share the same release kinetics: ~25% neuropeptide is released and the release is slow 
(i.e. t ½ ~10 s) (Figure 17A). Anterograde or retrograde DCVs that were visiting or captured both 
showed similar release kinetics (Figure 17B, C). No differences in release kinetics were seen 
between anterograde and retrograde vesicles (Figure 17D). Together, these results suggest that 
newly arrived DCVs that are visiting or captured at the distal or proximal boutons, from 
anterograde or retrograde directions, mobile or stationary, all undergo exocytosis with the same 
probability and release kinetics. 
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Figure 17 Neuropeptides are released partially and slowly independent of DCV transport directions and 
bouton locations 
a) Average time-course of neuropeptide release from releasable anterograde DCVs captured at a proximal (n=8) or 
distal bouton (n=5) for >2 min.. B. Average time-course of release for releasable captured (n=13) or visiting 
(Residence time : 5s-1 min, n=3) vesicles. C. Average time-course of release for retrograde DCVs, Capture, n=6 ; 
Visiting, n= 5. D. Average time-course of neuropeptide release from releasable anterograde (n=13) and retrograde 
(n=6) DCVs. All images were acquired at 1 s/ frame. Data points are averaged from 5 consecutive time points. 
Values are means ±S.E.M .Shaded area, 1 min 70 Hz stimulation.  
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3.3.3 Release kinetics of neuropeptides 
To determine whether the slow release kinetics was caused by the extended stimulation protocol, 
a shorter stimulation protocol (10 s) was applied to induce release. Unexpectedly, release 
continued for another 30s after stimulation stopped, implying that either the fusion pore opening 
persisted after stimulation or that neuropeptides were released as a stable deposit that diffuses 
away slowly from the membrane surface (Figure 18A). By applying multiple 10 s 70 Hz 
stimulations at 1 min intervals, we found that the same DCV can undergo multiple rounds of 
exocytosis, although the amount of release decreases with increasing number of stimulations 
(Figure 18B and C). The difference in release amount after repetitive stimulation excluded the 
possibility that exocytosis was detected from a packet of multiple DCVs in the SPAIM 
experiment. Rather, release is from the same DCVs. 
To test if such prolonged release from single DCVs is the result of kiss-and-run 
exocytosis, some preliminary release experiments were done with inhibition of endocytosis using 
Dynasore, a dynamin-specific inhibitor (Kirchhausen et al., 2008; Macia et al., 2006). In these 
experiments, neuropeptide released from a individual bouton with many DCVs upon 1 min 70 
Hz stimulation was measured after 30 min incubation with 100 μM Dynasore. Unexpectedly, 
exocytosis was nearly completely abolished in 2/3 of the experiments, while the rest showed a 
two-fold increase in neuropeptide release as compared to the DMSO-treated control. Activity-
dependent capture was also abolished upon Dynasore treatment. (Figure 18D). Future 
experiments using dyngo-4 (Harper et al., 2011), a newer version of Dynasore with higher 
dynamin I specificity, or overexpression of a temperature sensitive dynamin mutant, UAS-
Shibire-TS (Chen et al., 1991; Kitamoto, 2001), will be needed to further explain the release 
property of single DCVs.  
 66 
 
 
Time (s)
N
e
u
ro
p
e
p
ti
d
e
 R
e
le
a
s
e
( 
%
 F
)
0 30 60 90 120 150 180
0
10
20
30
40
50
N
e
u
ro
p
e
p
ti
d
e
 R
e
le
a
s
e
(
%
 F
)
1s
t S
tim
2n
d 
St
im
3r
d 
S
tim
0
5
10
15
20
Time(s)
N
e
u
ro
p
e
p
ti
d
e
 R
e
le
a
s
e
(
%
 F
)
-30 0 30 60 90 120 150 180
-10
0
10
20
30
40
50
Dynasore- No Release (n=8)
DMSO (0.125%) (n=8)
Dynasore- Release (n=3)
D
B C
Time (s)
N
e
u
ro
p
e
p
ti
d
e
 R
e
le
a
s
e
(
%
 F
)
-15 0 15 30 45 60
0
10
20
30
40
10s Stim
60s Stim
A
 
Figure 18 DCVs can undergo multiple rounds of exocytosis with release persisted long after stimulation 
a) Average time-course of neuropeptide release from anterogradely captured DCV upon 10s  (n=12) or 60s (n=17) 
70 Hz stimulation. Striped area, 10s stimulation period. Shaded area, 60s stimulation period.  b) Average time-
course of neuropeptide release from anterogradely captured DCV upon multiple 10s 70 Hz stimulation. Shaded area, 
10s stimulation period.  c) Amount of release after consecutive stimulations. Values were obtained by averaging the 
release amount at each time point from t=40-70 s after stimulation. d) Average time-course of neuropeptide release 
from individual bouton after 30 min 100uM Dynasore (n=12) or 0.125% DMSO treatment (n=8). All images were 
acquired at 1 s/ frame. Data points are averaged from 5 consecutive time points. Values are means ±S.E.M. 
 67 
3.4 DISCUSSION 
3.4.1 Releasability is independent of transport direction age and mobility  
These data suggest that DCVs that are constantly delivered to the nerve terminal through 
bidirectional sporadic capture (see Chapter 3 for the circulation strategy) are release-competent 
(~70% release probability), but release only partially. If we assume that most anterograde DCVs 
are young vesicles that are recently synthesized from the soma and retrograde DCVs are older 
vesicles that have resided in the terminal for a longer time, these findings may indicate that 
young and old DCVs are similar in terms of releasability. The fact that anterograde DCVs 
undergo exocytosis during their brief visits also suggests that DCVs are primed for release before 
they enter a bouton. One would expect that mobility facilitates release (Shakiryanova et al., 
2005,   Shakiryanova et al., 2007), but our data do not support such a bias. Transiting DCVs are 
not able to exocytose (data not shown), indicating that interbouton movement (likely driven by 
microtubule-based transport) does not favor release. Intrabouton motions such as jittering and 
looping allow for exocytosis but do not enhance releasability. These are distinct exocytosis 
properties of DCVs in the nerve terminal that are different from what were found in  endocrine 
or neuronal cell cultures previously (see Introduction). 
3.4.2 Kiss and run exocytosis as the predominant role of release 
Releasable DCVs released only ~25% of their content even when strong and prolonged 
stimulation was applied, indicating that kiss-and-run is the predominant mode of exocytosis for 
DCVs.  These data are in strong agreement with the finding from the neurite of developing 
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hippocampal neurons, in which only ~30% of Anf-GFP is released from single DCVs in each 
exocytic event upon high potassium-evoked depolarizarion (Xia et al., 2009). Nevertheless, 
contrasting findings were found in PC-12 cells, where fast, complete release of Anf-GFP was 
seen upon stimulation by Ba
2+
 or 500ms depolarization. This indicates that cell types and 
stimulation protocol may affect the efficiency of release (Barg et al., 2002; Han et al., 1999). At 
the same time, preselection by SPAIM for newly arrived DCVs may also be a cause for such 
discrepancy. It is possible that resident DCVs, which were not examined in the study are more 
likely to undergo full collapse fusion.   
We found that partially emptied vesicles are capable to undergo multiple rounds of kiss-
and-run exocytosis to release neuropeptide gradually. DCV recycling may serve as a mechanism 
utilized by the neuron to minimize the depletion of DCVs at nerve terminals upon repetitive 
firings, which would require the delivery of new DCVs from the remote synthesis/packaging 
site. In fact, repetitive kiss-and-run exocytosis has been reported previously upon single nerve 
stimulation, but those events are more rapid and are most likely due to the formation of 
flickering fusion pores (Staal et al., 2004; Xia et al., 2009). It is possible that DCVs in the fly 
NMJ also flicker, but the high signal noise and low temporal resolution of the SPAIM imaging 
have prevented us from detecting such events.  
The requirement for vesicle scission during kiss-and run was examined by dynamin 
inhibition. However, preliminary experiments using Dynasore to inhibit dynamin-mediated 
endocytosis showed varying results: either release was inhibited or more release was seen. 
Therefore, future SPAIM experiment using dyngo-4 (Harper et al., 2011), a newer version of 
Dynasore with higher dynamin I specificity, or overexpression of the temperature sensitive 
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dynamin mutant, UAS-Shibire-TS (Chen et al., 1991; Kitamoto, 2001), will be needed to further 
explain the release properties of single DCVs.  
3.4.3 Imaging single DCV exocytosis at a live nerve terminal 
SPAIM is a powerful technique to trace single DCV movement and to measure DCV flux at 
specific regions of the neuron by limiting newcomer DCVs from entering the imaging region of 
interest (Chapter 2). By combining SPAIM and electrical stimulation, the release of 
neuropeptides from single DCVs upon repeated stimulations was measured for the first time at 
live synaptic terminals.  
The key for single particle tracking is to limit the number of visible particles during 
imaging. In conventional TIRF imaging, particle number can be limited by visualizing only the 
in-focus DCVs close to the membrane. In this setting, much information about the 3D movement 
of DCVs is lost once they move out of focus. In addition, although DCVs can be resolved to a 
single vesicle level, a large number of DCVs are still present in the ROI, therefore most DCV 
can only be monitored for one round of  exocytosis, making it difficult to study DCV kinetics 
after multiple stimulations. In SPAIM, the number of visible particles in the ROI can be 
minimized down to one single DCV by simultaneous photobleaching. In addition, because 
imaging can be done by conventional confocal or widefield microscopy, the focal plane can be 
adjusted while imaging, and the lateral movement of DCVs away from the release sites can also 
be traced. This allows the same vesicle to be tracked before and after multiple rounds of 
stimulation.  Lastly, SPAIM is a particularly valuable tool to study DCV exocytosis in 
Drosophila larval preparation. Because fly boutons are much smaller than a whole endocrine 
cell, and because they are embedded inside the muscle, patch clamping is difficult and thus 
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capacitance measurements of DCV fusion are not feasible. Due to the unique anatomic 
orientation of the NMJ after dissection, it is impossible to place a coverslip on the preparation, 
and thus TIRF imaging is also impossible.  
Despite all the advantages of the SPAIM strategy, there are some limitations for its use to 
study DCV dynamics and kinetics. First, due to the nature of the photobleaching experiment, 
SPAIM preselects for DCV new comers. Therefore the data may not be representative of all 
DCVs because it does not include resident population. Second, image acquisition is labor-
intensive and data can be very noisy because DCVs are constantly moving in a 3-dimensional 
space that requires constant re-focusing. For the same reason, brighter and more stationary DCVs 
may be preselected for imaging. Therefore, further advancement of the imaging system will be 
needed to improve the strategy. 
3.5 MATERIALS AND METHODS 
The Drosophila line, elav>Anf-GFP (elav-Gal4C155 UAS-preproAnf-EMD) was maintained as 
double homozygotes for both transgenes, with female larvae selected for imaging experiments. 
All animals were raised at 25
o
C and fed on Jazzmix food (Fisher Scientific). 
Wandering 3rd instar larvae were filleted and imaged (Levitan et al., 2007) in Ca
2+
-free 
HL3 solution (in mM:  70 NaCl, 5 KCl, 0.5 Na3EGTA, 20 MgCl2, 10 NaHCO3, 5 trehalose, 115 
sucrose, and 5 HEPES, pH 7.2) .  
Imaging was performed with an upright Olympus Fluoview FV1000 confocal laser 
scanning microscope equipped with an 80/20 beamsplitter in the laser combiner, a second “SIM” 
scanner, a dichroic mirror to recombine the SIM and main scanner beams, and a Olympus 
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LUMFL 60X (NA 1.1) water immersion objective. GFP was imaged using 488 nm excitation 
lasers, respectively at a frame rate of 1 Hz.  In SPAIM experiments, initial photobleaching was 
performed using 488 nm SIM scanning at speed of 100 m/pixel and 100% SIM laser power.  
Then the SIM scanner setting was reduced to 20%-30% power for simultaneous photobleaching 
while acquiring images with the main scanner. After a DCV was seen to have resided at a bouton 
for a specific period, motor nerves were stimulated with suction electrodes at 70 Hz for either 1 
minute or 10 s.  
Drugs were bath applied after dissection. Dynasore was obtained from Sigma-Aldrich 
(St. Louis, MO), and was dissolved in DMSO as stocks (80 mM) and subsequently diluted to 
yield a final concentration of 0.125% DMSO.  
Images were analyzed using ImageJ software (NIH). For intensity measurements, a 
region of interest was drawn around each DCV at each time point and background subtracted 
GFP fluorescence was measured as the mean grey value unless otherwise specified. 
Neuropeptide release was quantified as the change of percent fluorescence prior to stimulation 
(Δ%F) unless otherwise specified. Data points were binned every 5 time points to reduce data 
noise. Single DCVs were tracked and trajectories were plotted using the Manual Tracking plugin 
in ImageJ. 
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4.0  PRESYNAPTIC RYANODINE RECEPTOR-CAMKII SIGNALING IS 
REQUIRED FOR ACTIVITY-DEPENDENT CAPTURE OF TRANSITING VESICLES. 
4.1 ABSTRACT 
Activity elicits capture of dense-core vesicles (DCVs) that transit through resting Drosophila 
synaptic boutons to produce a rebound in presynaptic neuropeptide content following release. 
The onset of capture overlaps with an increase in the mobility of DCVs already present in 
synaptic boutons. Vesicle mobilization requires Ca
2+
-induced Ca
2+
 release by presynaptic 
endoplasmic reticulum (ER) ryanodine receptors (RyRs) that in turn stimulates Ca
2+/
calmodulin-
dependent kinase II (CamKII). Here we show that the same signaling is required for activity-
dependent capture of transiting DCVs. Specifically, the CamKII inhibitor KN-93, but not its 
inactive analog KN-92, eliminated the rebound replacement of neuropeptidergic DCVs in 
synaptic boutons. Furthermore, pharmacologically or genetically inhibiting neuronal sarco-
endoplasmic reticulum calcium ATPase to deplete presynaptic ER Ca
2+
 stores or directly 
inhibiting RyRs prevented the capture response. These results show that the presynaptic RyR-
CamKII pathway, which triggers mobilization of resident synaptic DCVs to facilitate exocytosis, 
also mediates activity-dependent capture of transiting DCVs to replenish neuropeptide stores. 
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4.2 INTRODUCTION 
The function of nerve terminals depends on vesicular delivery of proteins synthesized in the 
soma to synaptic boutons. Transport vesicles are known to contain channels, active zone 
constituents and neuropeptides (Ziv and Garner, 2004; Zupanc, 1996). In contrast to synaptic 
membrane proteins and classical transmitters that are recycled following exocytosis, 
neuropeptide release is irreversible. Thus, peptidergic transmission depends on the replacement 
of neuropeptide-containing dense-core vesicles (DCVs). This is potentially a very slow process 
because delivery of vesicles synthesized in the soma to nerve terminals by fast axonal transport 
can take days. However, a cell biological strategy has been discovered that bypasses such delays. 
Activity-dependent capture of transiting vesicles utilizes a pool of DCVs that rapidly pass 
through the resting nerve terminal, but that are captured in response to a burst of activity 
(Shakiryanova et al., 2006a). The onset of this capture, which is evident as decreased DCV 
efflux and increased neuropeptide content in synaptic boutons, occurs over a period of minutes 
instead of the hours that would be required for conventional steady state DCV replacement. 
Essentially, the nerve terminal can tap into the transiting DCV pool to rapidly replenish 
neuropeptide stores without any direct involvement of the soma. Hence, activity-dependent 
capture of transiting DCVs eliminates the delay in delivering nascent DCVs, apportions 
resources based on activity and places control of synaptic neuropeptide storage at sites of release 
instead of the site of synthesis (i.e. the soma) (Shakiryanova et al., 2006a). A similar recruitment 
process also occurs with neurotrypsin-containing vesicles, which were concluded to rapidly 
undergo exocytosis following stimulated capture (Frischknecht et al., 2008). Likewise, vesicle 
capture appears to be involved in release of presynaptic Wnt/Wingless protein (Ataman et al., 
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2008). Therefore, activity-dependent capture of transiting vesicles supports synaptic 
neuropeptide, enzyme and developmental peptide release. 
The signaling required for activity-dependent capture of transiting DCVs is unknown. 
The long duration of this response in Drosophila motor neurons (i.e., for ∼0.5 hour) coupled 
with the requirement for electrical activity suggests a potential involvement of Ca
2+
-induced 
phosphorylation. In fact, recent experiments have shown that such signaling increases the 
mobility of resident DCVs in synaptic boutons. Mobilization, which is triggered by Ca
2+
 influx 
and persists for ∼10 minutes (Shakiryanova et al., 2005), requires Ca2+-induced Ca2+ release 
from presynaptic endoplasmic reticulum (ER) via ryanodine receptors (RyRs) (Shakiryanova et 
al., 2007). Subsequently, Ca
2+
/calmodulin-dependent protein kinase II (CamKII) is activated as a 
necessary step for DCV mobilization (Shakiryanova et al., 2007). The overlapping onset of the 
capture and mobilization responses in the first minutes following a brief tetanus stimulated us to 
investigate whether the RyR-CamKII pathway participates in activity-dependent capture of 
transiting vesicles. 
Here a GFP (Green Fluorescent Protein)-tagged neuropeptide is imaged at the intact 
Drosophila neuromuscular junction. We report that the rebound in synaptic neuropeptide stores 
following activity-evoked release, which is caused by capture of transiting vesicles 
(Shakiryanova et al., 2006a), requires RyR-mediated Ca
2+
 efflux from presynaptic ER and 
activation of CamKII. Therefore, RyR-CamKII signaling initiates both mobilization of resident 
DCVs within synaptic boutons and capture of DCVs from the rapidly transiting pool.  
This chapter has been published as “Presynaptic Ryanodine Receptor-CamKII Signaling 
is Required for Activity-dependent Capture of Transiting Vesicles” in Journal of Molecular 
Neuroscience in January 2009 (Wong et al., 2009). The work was contributed by my advisor Dr. 
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Edwin Levitan for the preparation of the manuscript. It was also contributed by Drs. Dinara 
Shakiryanova, Chaoming Zhou, David Deitcher for experimental advice and the generation of 
genetic mutants. 
 
4.3 RESULTS 
Drosophila type Ib boutons were electrically stimulated to induce release and subsequent capture 
of transiting DCVs. Prior to stimulation, the signal from the GFP-tagged neuropeptide was stable 
within a bouton. However, 70 Hz motor nerve stimulation for a minute induced a rapid release of 
∼20% of the neuropeptide (i.e., fluorescence dropped to ∼80% of the resting value). This was 
followed by a rebound in the following 4 minutes to reach ∼90% of the baseline content (Figure 
20), which is mediated by capture of transiting DCVs (Shakiryanova et al., 2006a). Hence, 
capture of transiting DCVs resulted in rapid replacement of ∼50% of the neuropeptide release by 
synaptic boutons. 
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Figure 19 Activity-dependent neuropeptide capture following electrical stimulation 
A. Pseudo-color images of GFP-tagged neuropeptide fluorescence in a type Ib bouton before and after 70 Hz 
electrical stimulation for 1 minute. The relative amount of peptide content was quantified as percentage fluorescence 
prior to stimulation (%F). B. Time course of neuropeptide content (n=12). Black bar indicates stimulation. Each 
experimental point was from one bouton in an independent preparation. Error bars represent standard error of the 
mean (SEM). Note the rebound in neuropeptide content following release, which is caused by activity-dependent 
capture of transiting DCVs (Shakiryanova et al., 2007). 
 
To determine whether CamKII activity is required for activity-dependent DCV capture, 
we examined the effect of CamKII inhibition on the response to the above electrical stimulation. 
Specifically, the effect of the CamKII inhibitor KN-93 was compared to its inactive analog KN-
92. Both compounds slightly increased acute release (i.e. the rapid drop in GFP fluorescence 
immediately following stimulation) (Figure 20). This minor response, which was not seen with a 
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different stimulation protocol (Shakiryanova et al., 2007), must not involve CamKII because it 
was produced by both analogs. However, a concentration of KN-93 that abolishes activity-
evoked DCV mobilization (Shakiryanova et al., 2007) eliminated the subsequent rebound of 
neuropeptide content, while the capture response remained detectable with KN-92 (Figure 20). 
To normalize for potential differences in release, capture was quantified as the percent of 
released neuropeptide that was replaced in 4 minutes after the cessation of electrical stimulation. 
Based on this analysis, KN-93 and KN-92 produced statistically different results (Figure 21, 
left). Hence, although the KN compounds may have had a shared minor nonspecific effect on 
release, the KN-93-specific inhibition of the rebound in neuropeptide content implies that 
CamKII activity is required for activity-dependent capture of transiting DCVs. 
 
 
 
Figure 20 CamKII inhibition abolishes activity-dependent DCV capture 
CamKII inhibition abolishes activity-dependent DCV capture. Neuropeptide content time course following 15-
minute pretreatment with 10 μM KN-92 (filled triangles, n=4) or KN-93 (open circles, n=6). Black bar indicates 
70Hz electrical stimulation. Error bars represent SEM. 
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Because activation of CamKII for DCV mobilization requires ER Ca
2+
 release mediated 
by RyRs (Shakiryanova et al., 2007), the role of RyRs in activity-dependent DCV capture was 
studied. Pretreatment with an inhibitory concentration of ryanodine eliminated capture (i.e. the 
replacement of released neuropeptide was not significantly different from zero) (Figure 21). To 
independently verify that ER Ca
2+
 release was required, ER Ca
2+
 stores were depleted by 
inhibiting the Sarco/Endoplasmic Reticulum Ca
2+
-ATPase (SERCA) with Thapsigargin (Tg) in 
Ca
2+
-free medium for 20 minutes. The preparation was then returned to normal Ca
2+
-containing 
solution and electrically stimulated. This protocol dramatically reduced the capture response, 
while a vehicle control had no effect (Figure 21). Thus, release of ER Ca
2+
 by RyRs is required 
for activity-dependent capture of transiting DCVs. 
The pharmacologic agents used thus far were bath applied and so acted on both the 
presynaptic neuron and the postsynaptic muscle. To ensure activity-dependent DCV capture is 
not caused by retrograde RyR-induced signaling, presynaptic ER Ca
2+
 stores were targeted 
genetically by expressing a temperature-sensitive dominant negative SERCA subunit (Kum170, 
(Sanyal et al., 2005) specifically in neurons. At a permissive temperature, the capture response in 
Kum170-expressing boutons was intact. However, replacement of released neuropeptide was 
inhibited after shifting the animals to the restrictive temperature for 8 minutes (Figure 21, right). 
In contrast, this treatment did not affect capture in control animals subjected to the restrictive 
temperature (data not shown). Therefore, presynaptic ER Ca
2+
 release by RyRs is essential for 
CamKII-mediated capture of transiting DCVs. 
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Figure 21 CamKII and presynaptic Ca2+ release by ER RyRs are required for activity-dependent DCV 
capture 
Comparison of capture after inhibiting CamKII with KN-93 (n=6) or treating with an inactive analog KN-92 (n=4), 
inhibiting RyRs with 100 μM ryanodine (n=6) for 15 minutes versus untreated controls (n= 12), and ER Ca2+ store 
depletion by the SERCA pump inhibitor Tg (20 μM, n=5) for 20 minutes versus its vehicle control (n=6). Finally, 
the requirement for presynaptic ER Ca2+ release was tested in animals expressing temperature-sensitive dominant 
negative SERCA pre-exposed for 8 minutes to 22°C (Kum170, n=6) or 40°C (Kum170 + heat, n=10). Unpaired t-
test results: *P < 0.05, **P < 0.01 , ***P < 0.001. # indicates no significant difference from zero by one sample t-
test. Error bars represent SEM. 
4.4 DISCUSSION 
In vivo imaging has shown that a brief bout of activity elicits prolonged DCV mobilization and 
capture. These processes are independent because capture requires axonal transport while 
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mobilization does not (Shakiryanova et al., 2005; Shakiryanova et al., 2006a). Nevertheless, the 
onsets of mobilization of resident DCVs and capture of transiting DCVs overlap (i.e. both 
develop over minutes following seconds of activity). This observation stimulated us to test the 
hypothesis that these two mechanisms are initiated by the same signaling. Previous studies had 
established that Ca
2+
 influx triggers DCV mobilization by activating RyR-mediated Ca
2+
 release 
from presynaptic ER that in turn stimulates CamKII (Shakiryanova et al., 2007). The 
pharmacological and genetic experiments presented here establish that RyR-CamKII signaling is 
also required for activity-dependent capture of transiting DCVs. 
This finding raises the issue of how a single signaling pathway produces responses with 
different durations: after seconds of activity, DCV mobilization lasts ∼10 minutes, while the 
capture response lasts ∼40 minutes (Shakiryanova et al., 2005; Shakiryanova et al., 2006a). One 
possible consideration is that these kinetic differences could originate in the processes 
responsible for reversal of mobilization and capture. Specifically, RyR-CamKII signaling could 
initiate the two processes in parallel, but dephosphorylation of distinct CamKII substrates might 
occur at different rates, possibly because of the involvement of different phosphatases. This 
potential explanation suggests that identifying the CamKII substrates that mediate mobilization 
and capture will be important for understanding the diversity in long-lasting responses initiated 
by activity-triggered presynaptic RyR-CamKII signaling. Recently, CamKII-dependent 
phosphorylation of kinesin superfamily protein 17 (KIF17) was found to be essential for 
unloading NMDA receptor-carrying cargoes from microtubules near the postsynaptic density 
(Guillaud et al., 2008). Therefore, CamKII might induce capture by triggering dissociation of 
transiting DCVs from their molecular motor dynactin complex, which would contain both a 
kinesin-3 family member UNC-104/Kif1 (Barkus et al., 2008; Pack-Chung et al., 2007b) and a 
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dynein retrograde motor, while mobilization might depend on another CamKII substrate. 
Alternatively, some process downstream of dephosphorylation might be rate determining for 
reversal of capture. For example, once captured vesicles are committed to return to the transiting 
pool, they might need to recruit an unoccupied motor complex to support rapid transiting. If such 
complexes are rare, then recovery from capture would be very slow. In contrast, recovery from 
mobilization, which does not require exiting from the bouton, would not be limited in the same 
way. Regardless of the specific basis for the diverse time courses of mobilization and capture, 
the use of the same signaling pathway to induce both of these effects is an elegant means to 
ensure that facilitation of release is coupled to replacement of depleted synaptic neuropeptide 
stores. 
4.5 MATERIALS AND METHODS 
Drosophila melanogaster expressing Emerald GFP-tagged atrial natriuretic factor in 
neurons (elav-Gal4 UAS-preproANF-EMD) were used as previously described (Levitan et al., 
2007; Rao et al., 2001a; Shakiryanova et al., 2006a). elav-GAL4 UAS-preproANF-EMD; UAS-
Kum170/CyO, Act-GFP animals express the temperature-sensitive dominant negative SERCA 
Kum170 mutant in neurons (Sanyal et al., 2005; Shakiryanova et al., 2006a). SERCA was 
inactivated by incubating these animals in Ca
2+
-free HL3 saline (70 mM NaCl, 5 mM KCl, 20 
mM MgCl2, 115 mM sucrose, 5 mM trehalose, 5 mM HEPES, 10 mM NaHCO3, 0.5 mM EGTA, 
pH 7.25) at 40°C for 8 minutes. 
Female third instar wandering larvae were filleted in Ca
2+
-free HL3 saline. The ventral 
ganglion was severed to eliminate central input to the motor neurons that induces muscle 
 82 
contraction. During live imaging and electrical stimulation, animals were bathed in HL3 saline 
(70 mM NaCl, 5 mM KCl, 1.5 mM CaCl2, 20 mM MgCl2, 115 mM sucrose, 5 mM trehalose, 5 
mM HEPES, 10 mM NaHCO3, pH 7.25) supplemented with 10 mM L-glutamate (HL3-Glut). L-
glutamate was included to desensitize postsynaptic glutamate receptors and minimize muscle 
contraction during imaging experiments. Type Ib synaptic boutons located on muscles 6 and 7 in 
segments A3 to A6 were imaged using a cooled CCD camera on an upright wide-field 
epifluorescence microscope with 40× or 60× water-immersion objectives. Motor nerves were 
stimulated with suction electrodes at 70 Hz for 1 minute. Capture was calculated as the percent 
of recovery of peptide fluorescence four minutes after the cessation of stimulation normalized to 
release (i.e., the initial drop in fluorescence immediately after electrical stimulation). 
Drugs were bath applied after dissection. Ryanodine (high purity, water soluble), KN-92 
and KN-93 were obtained from Calbiochem, La Jolla, CA. KN-92 and thapsigargin (Alamone 
labs, Jerusalem, Israel) were dissolved in DMSO as stocks and subsequently diluted to yield a 
final concentration of 0.05% DMSO. 
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5.0  DISCUSSION 
5.1 SUMMARY AND SIGNIFICANCE OF FINDINGS 
Because protein synthesis and packaging machinery are not present at the nerve terminal, 
neuropeptides are made and packaged into dense core vesicles (DCVs) exclusively at the remote 
cell body. For this reason, accurate and timely delivery of DCVs from the cell body to the nerve 
terminal is crucial to constantly replenish released neuropeptides. At the same time, because 
neurons undergo repetitive firing, neuropeptide release at the nerve terminal must be tightly 
regulated to avoid storage depletion. Therefore, it is important to understand  how neuropeptides 
are supplied and released at the nerve terminal at steady state to maintain nerve function. 
Traditionally, it was believed that DCVs are delivered to the nerve terminal exclusively 
through anterograde fast axonal transport. However, it is now known that DCVs are continuously 
transiting bidirectionally along the axon and at resting nerve terminal. In addition, nerve 
terminals have very complex architecture.  They are highly branched with release sites located in 
en passant boutons. It is unclear how DCVs can be delivered to these diverse sites evenly at the 
nerve terminal. Although DCV exocytosis and neuropeptide release have been extensively 
studied and much is known about the neuropeptide releasability, such studies were performed in 
endocrine cell cultures in which special polarized and differentiated features of neurons are 
absent. Therefore, the native mechanism used by DCVs to release neuropeptide at the synaptic 
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terminal was not known.  For these reasons, it is essential to use a differentiated neuron system 
to further our understanding on DCV trafficking and exocytosis. In this thesis, GFP-tagged 
neuropeptides (Anf-GFP) were expressed and imaged in vivo at the fly larval NMJ to study DCV 
transport and exocytosis. 
Chapter 2 examined how neuropeptides are delivered to the nerve terminal via 
bidirectional DCV transport. We first used inducible gene expression systems to pulse-label 
DCVs at the NMJ. It was found that newly synthesized DCVs preferentially accumulate at the 
most distal bouton. Next, FRAP was performed at terminals constitutively expressing Anf-GFP. 
DCVs were found to recover the fastest at the most distal bouton even under calcium-free 
conditions, suggesting that the DCV gradient seen was not due to differential release at proximal 
boutons. High-frequency timelapse imaging after photobleaching showed that most newly 
arrived anterograde DCVs bypass proximal boutons and accumulate at the most distal bouton, 
suggesting that DCVs are preferentially delivered to the most distal bouton. A novel optical 
technique called SPAIM was developed to track single DCV movement. In this experiment, a 
nerve terminal is first photobleached and allowed for recovery. Immediately after the first 
labeled DCV arrives at the nerve terminal, a second laser scanner is used to photobleach all the 
newcomers at the proximal end of the terminal while the main scanner continue to 
simultaneously image the movement of the first vesicle.  Vesicle trajectories showed that DCVs 
take a complex journey (pausing, looping, direction reversal) to arrive at their destinations. They 
also revealed 3 classes of kinetic events upon arrival at a bouton. DCV may be visiting for a 
short time (residence time <2 min), captured for a prolonged period (>=2 min), or bypass the 
bouton (<5 s). Capture events were most frequent at the most distal bouton. These results suggest 
that the initially polarized accumulation of neuropeptide is caused by the sporadic proximal 
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capture of anterograde DCVs as they make their complex journey through the terminal. 
Disrupting retrograde transport by overexpression of dynactin mutant subunits caused 
accumulation of neuropeptides at the most distal boutons. These retrograde DCVs are also 
captured sporadically at proximal boutons, as shown from their SPAIM trajectories. The routes 
taken by these retrograde DCVs were also examined at the branch point of nerve terminals. 
Retrograde DCVs mostly return to the main axon and never enter neighboring branches for 
delivery. SPAIM experiments revealed that, upon entering the proximal axon, returning DCVs 
can reverse direction and reenter the axon, possibly for another round of delivery. Together, the 
study shows that neuropeptide delivery in nerve terminal release sites is mediated by sporadic 
anterograde and retrograde capture of DCVs circulating between the proximal axon and distal 
boutons 
In Chapter 3, DCV exocytosis properties were examined at a single vesicle level in the 
fly NMJ using different SPAIM paradigms. It was found that DCVs that are 1) delivered from 
the anterograde or retrograde directions, 2) captured or just visited for a brief period, and 3) 
delivered to proximal or distal boutons are all capable of supporting release. Furthermore, 
labeled DCVs retained a significant fraction of fluorescence upon stimulation, indicating that 
neuropeptides are released incompletely and that kiss-and-run exocytosis predominates. In 
addition, neuropeptides are released very slowly (i.e., release may last for up to 30s), suggesting 
that diffusion of neuropeptides from DCVs may be limited by the size of the fusion pore during 
kiss-and-run exocytosis. By tracking the same DCVs for extended period while stimulating the 
nerve multiple times, it was found that partially emptied DCVs can undergo multiple rounds of 
exocytosis. Overall, the study suggests that neuropeptide stored at the terminal is utilized 
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progressively through partial release and local recycling of DCVs, thus minimizing the supply of 
newly synthesized DCVs from the remote cell body. 
Chapter 4 examined the signaling pathway involved in activity-dependent capture of 
DCVs.  By measuring intensity changes of GFP labeled DCVs at the NMJ bouton before and 
after electrical stimulation, the amounts of neuropeptide release and activity-dependent capture 
were determined. The CamKII inhibitor KN-93, but not its inactive analog KN-92, abolished the 
replenishment of neuropeptidergic DCVs in synaptic boutons after release. Furthermore, 
pharmacologically or genetically inhibiting neuronal SERCA pump to deplete presynaptic ER 
Ca
2+
 stores or directly inhibiting RyRs prevented the capture response. These results suggest that 
presynaptic RyR-CamKII pathway is shared by two different cellular processes to mobilize 
DCVs and capture transiting DCVs after activity. 
The studies presented in the thesis demonstrate elegant mechanisms utilized by the 
neuron to maintain efficient neuropeptide secretion. By keeping a constant supply through 
bidirectional capture and minimizing the overuse of DCVs at the nerve terminal, the 
neuropeptide store is not depleted under repetitive firing. The circulation strategy used by DCVs 
to deliver neuropeptides explains why defects in retrograde transport may contribute to 
neurodegenerations. The work also developed a novel strategy to track single DCVs in nerve 
terminals for a prolonged period, which can be applied to study trafficking and dynamics of other 
organelles. Overall, this dissertation provides new insight into the macroscopic and biophysical 
properties of DCVs on trafficking and exocytosis at the nerve terminal. These will facilitate 
future research to identify molecular players for neuropeptide transmission and possible drug 
targets to combat related diseases. 
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5.2 EFFECTIVE SUPPLY OF NEUROPEPTIDES THROUGH A CELLULAR 
CONVEYOR SYSTEM  
Considering that protein synthesis and motor driven transport are both energy-demanding 
processes, it is surprising that neuropeptide delivery operates by making and transporting excess 
DCVs to the most distal bouton first.  Nevertheless, it may be the most optimal mechanism to 
distribute DCVs evenly to en passant boutons. Given that there is no known addressing system 
to target cargoes to a specific bouton along the dynamic terminal, DCVs may have been 
randomly distributed at each en passant bouton with equal probability. However, in this case, 
proximal boutons would always gain earliest access to anterograde DCVs and the most distal 
bouton would be loaded with fewer DCVs. Therefore, by constantly transporting excess DCVs to 
the most distal end, all proximal boutons are given an equal chance to encounter vesicles and 
capture some of them for storage. Excess DCVs accumulate at the most distal bouton can then be 
removed by retrograde transport and given another chance to explore proximal boutons for 
delivery. More importantly, this circulation strategy allows every bouton to be replenished upon 
activity-evoked exocytosis by capturing transiting DCVs (Shakiryanova et al., 2006a). 
Uncaptured DCVs, however, can return to the proximal axon, reverse direction and reenter the 
terminal again for another round of delivery. An analogy to this circulation route would be the 
conveyor system, which is widely used in industries as the most efficient and economical system 
to distribute products to diverse downstream processing units. Here, DCVs are analogous to 
products on a conveyor belt waiting to be removed somewhere along the line.  In this system, 
production can be controlled by sampling the rate of product return. It is possible that a 
molecular sensor is present at the proximal axon to assess the returning DCV flux and adjust 
protein synthesis and degradation thereafter. 
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Sporadic capture may have other physiological significance. It is now known that 
vesicles that carry important active zone precursors, piccolo-bassoon transport vesicles (PTVs), 
share the same anterograde motor as DCVs, suggesting that active zone proteins and other 
synaptic proteins (Hall and Hedgecock, 1991; Jacob and Kaplan, 2003; Okada et al., 1995) in 
addition to neuropeptides, are also delivered to en passant boutons using the same strategy 
(Goldstein et al., 2008; Pack-Chung et al., 2007b). Our data also suggest that the most distal 
bouton, which plays distinct roles in neurotransmission and neurodevelopment, is allowed to 
access newer/younger protein first. Despite the even distribution of the active zone protein 
(Bruchpilot, Brp) in the fly NMJ (Kittel et al., 2006; Wagh et al., 2006), several studies have 
shown that synaptic strength changes across en passant boutons. As measured by Ca
2+
 influx at 
the post-synapse, a steep gradient of synaptic strength was seen across en passant bouton, with 
the most distal bouton having the strongest presynaptic release (Guerrero et al., 2005). The single 
action potential Ca
2+
 transient also decreases from the distal to the proximal bouton (Lnenicka et 
al., 2006). It is also known that the most distal bouton is more dynamic and plastic (Dent et al., 
1999; Hummel et al., 2000; Roos et al., 2000).  
5.3 CONSERVED NEUROPEPTIDE USE VIA PROGRESSIVE KISS-AND-RUN 
EXOCYTOSIS 
Kiss-and-run is the exclusive mode of exocytosis for newly arrived DCVs at the fly NMJ. This is 
in strong agreement with previous findings based on endocrine and neuronal cultures as the 
model system (Ceridono et al., 2011; Ferraro et al., 2005; Xia et al., 2009). In fact, kiss-and-run 
is a more desirable mode of exocytosis for DCV for many reasons. First, the progressive release 
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will prevent the depletion of DCVs under repetitive firing of the neuron, as the supply of DCV is 
limited by the synthesis and delivery from the soma. The ability of DCVs to undergo multiple 
rounds of exocytosis allows local recycling of resources, thus minimizing the demand of DCV 
supply. Secondly, it provides an additional strategy for the nerve terminal to regulate amount of 
neuropeptide release locally. Unlike SSVs, in which quantal content is determined locally 
through the regulation of vesicular transporters and quantal size can be controlled instantly at the 
nerve terminal. For DCVs, neuropeptide content is determined by expression levels and 
packaging efficiency at the site of synthesis in the soma. In this case, quantal size is regulated at 
a remote site with a long time delay. One may argue that neuropeptides can be packaged in more 
vesicles of smaller quantal size and so release can be regulated by quantal contents. However, 
this is an undesirable strategy because many more cellular resources will be needed to sort and 
deliver neuropeptides. Therefore, by utilizing kiss-and-run exocytosis, DCVs can control the 
amount of neuropeptide release by regulating other parameters locally, such as size of the fusion 
pore and duration of the open state. Lastly, the fusion pore in kiss-and-run can also serve as a 
size-dependent filter to select the type neurotransmitters (e.g. neuropeptides versus classical 
neurotransmitters) to be released (Fulop et al., 2005).   
5.4 POTENTIAL MECHANISM FOR CONSTITUTIVE AND ACTIVITY-
DEPENDENT CAPTURE 
Although the current study does not identify any molecular players mediating preferential 
transport, some speculation on the underlying mechanism can be made based on the structural 
organization of synaptic boutons. Because microtubule tracks in fly NMJ mostly extend to the 
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most distal bouton (Conde and Caceres, 2009), it is likely that DCVs are constitutively 
transported anterogradely by kinesin until they reach the end of microtubules and fall off.  
Interestingly, it is now known that the retrograde adaptor protein p150
Glued
, which is also 
required for retrograde transport initiation at the microtubule plus-end (Vaughan et al., 2002),  is 
localized most abundantly at the most distal bouton of fly NMJ (personal communication with 
Lloyd. T et al). Therefore the most distal bouton may serve as a hot spot for DCVs to be 
equipped with retrograde motor and reverse direction, facilitating vesicle circulation. It is 
tempting to think that dynamic microtubule plus-ends, which are responsible for the “search-and-
capture” retrograde transport initiation (Mimori-Kiyosue and Tsukita, 2003), are also more 
abundant at the most distal bouton. Nevertheless, by expressing the RFP-tagged microtubule 
plus-end binding protein (EB1-RFP) to examine the dynamic behavior of microtubule plus-ends 
(Mattie et al., 2010) (Figure A1, Movie S 8), it was found that dynamic plus-ends are evenly 
distributed across en passant boutons. These results may argue that in the nerve terminal, the 
search-and-capture mechanism is critical for retrograde transport.  
RyR-CamKII mediated activity-dependent capture was found to capture retrograde DCVs 
from the transiting pool (Shakiryanova et al., 2006). Apparently, such capture involves the 
unloading of retrograde DCVs from the microtubule track, either by disrupting the motor-
microtubule, or motor-vesicle interactions. Increasing evidence has shown that CamKII is 
involved in the regulation of motor-cargo interactions. At the post-synaptic density, CamKII 
phosphorylates the kinesin superfamily protein 17 (KIF17) and induces the dissociation of 
Mint1, a scaffolding protein complex, from NMDA receptor-containing cargoes (Guillaud et al., 
2008). CamKII also acts as a molecular switch to inhibit the interaction between myosin V and 
melanosomes in Xenopus melanophores through the phosphorylation of the myosin tail (Karcher 
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et al., 2001). Although myosin V has long been known to be an actin-based motor that also 
participates in short-range transport, a few studies have shown that myosin V is involved in the 
retrograde transport of DCVs and tetanus toxin-containing vesicles (Bittins et al., 2010; Lalli et 
al., 2003). The activity of KIF1A, the anterograde motor involved in DCV trafficking, may also 
be regulated by CamKII. A study has shown that CamKII phosphorylates the KIF1A/cargo 
adaptor protein, Liprin α. This causes the degradation of Liprin α through the ubiquitin-
proteasome system, and the dissociation of KIF1A from the cargo, leukocyte common antigen-
related (LAR) family receptor protein tyrosine phosphatases (Dunah et al., 2005; Hoogenraad et 
al., 2007; Shin et al., 2003). Although activity-dependent capture involves the unloading of 
retrograde transiting DCVs, and KIF1A is an anterograde motor, many lines of evidence suggest 
that KIF1A cooperates with dynein to coordinate bidirectional transport such that perturbing 
anterograde motors disrupts retrograde transport (Barkus et al., 2008; Lo et al., 2011). Therefore, 
it is possible that the phosphorylation of Liprin α by CamKII plays a role in unloading the 
retrograde DCV from kinesin motors. 
Interestingly, the same signaling pathway is shared with another axonal transport-
independent activity-dependent process, vesicle mobilization, which is more acute (~10 mins). 
This suggests to that CamKII may initiate vesicle mobilization by phosphorylating an 
independent substrate. Alternatively, the rate of dephosphorylation of CamKII substrates for 
capture and mobilization may be different.  Regardless of the specific basis for the diverse time 
courses of mobilization and capture, the use of the same signaling pathway to induce both of 
these effects is an elegant means to ensure that facilitation of release is coupled to replacement of 
depleted synaptic neuropeptide stores. 
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5.5 SIGNIFICANCE OF THE STUDY 
5.5.1 New insight into neurodegenerative diseases 
Conventional models suggest that impaired retrograde transport leads to misaccumulation of 
toxic materials at the periphery (Chevalier-Larsen and Holzbaur, 2006), and perturbs retrograde 
long-distance signaling from the nerve terminal  (Ilieva et al., 2009; Perlson et al., 2009), which 
further induces loss of synaptic function and finally cell death. This study suggests that defective 
retrograde transport also affects delivery of neuropeptides, which may contribute to the 
development of neurodegeneration. Thus far, studies regarding microtubule-based transport have 
mainly been focused on measuring the flux, velocity and pause-time of different cargoes along 
the axon (Bilsland et al., 2010) but not at the terminal, where loading and unloading of cargoes 
mainly takes place. Here, by understanding the trafficking pattern of DCV along en passant 
boutons, our study also provides new insight into how disrupted microtubule-based transport 
affects neuronal function at the subsynaptic level, which will eventually be helpful in 
understanding how molecular motors function. 
5.5.2 Technology Advancement 
The use of SPAIM has facilitated several important novel observations in native synapses. These 
include: 1) tracking single DCV movement; 2) measurement of DCV flux in a single direction in 
spite of their bidirectional movement; and 3) monitoring single DCV exocytosis at the terminal. 
Unlike the use of conventional TIRF, SPAIM allows DCVs to be tracked on different focal 
planes. Another advantage of SPAIM tracking is that experiments can be repeated simply by 
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rebleaching the same terminal and waiting for the next DCV to enter the region of interest, thus 
allowing pair-wise comparisons on the trajectory, mobility, and exocytosis properties of different 
vesicle from the same terminal. SPAIM also overcomes the difficulties associated with the use of 
photoactivatable proteins, which are usually more pH sensitive, dimmer and require critical 
environmental conditions for photoactivation. In principle, the technique can also be applied to 
other fluorescent organelles, such as receptor-carrying vesicles, mitochondria, and lysosomes to 
study traffic in diverse polarized cell structures. 
5.6 FUTURE DIRECTIONS 
More experiments will be needed to further characterize the properties of neuropeptide release. 
Release should be measured upon multiple rounds of short-duration (5 s) stimulation with longer 
recovery period. This set of experiment should better resolve the time course of peptide release 
between stimulations. We are also interested to see if DCVs can eventually be emptied after 
multiple rounds of stimulation. To further examine the role of dynamin and kiss-and-run 
exocytosis of DCVs, Dyngo-4a, a dynasore analogue with higher affinity to dynamin I, could be 
used to inhibit dynamin activity. Alternatively, a temperature sensitive dynamin mutant, shibire, 
can be used.  
Although the in vivo imaging technique applied in our studies is very powerful and has 
allowed many novel observations of DCV trafficking, there are limitations of the current 
technique. First, all the imaging experiments were based on ectopic overexpression of exogenous 
neuropeptides in motoneurons that do not normally release large amount of neuropeptide. 
Although we were able to show that the DCV circulation strategy is utilized by neurons to 
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deliver the native neuropeptide proctolin (Figure 9), suggesting that the trafficking mechanism 
reported is not an artifact from the neuropeptide overexpression, findings from the neuropeptide 
release studies may be artificial because the amount of neuropeptide in each DCV may be higher 
than the endogenous level. To understand the native release mechanism, a valuable approach 
could be to use an inducible-gene expression system to limit the neuropeptide expression level. 
Alternatively, it may be desirable to knock-in a GFP-tagged native fly neuropeptide that is 
expressed endogenously in the type III peptidergic neuron.  
With the new SPAIM technique, we can look further into the DCV transport properties 
within a bouton, such as activity-dependent vesicle mobilization. In addition, the delivery pattern 
of other organelles and vesicle cargoes, such as mitochrondria, active zones and receptor 
molecules, can also be studied. Further work needs to be done to elucidate local traffick 
properties. For example, how do acute changes in the morphology of branches and en passant 
boutons affect DCV transport? This can be studied by ablating specific neuronal regions with the 
use of a two-photon laser. Since the work presented in this thesis focuses only on the biophysical 
and macroscopic properties of DCV trafficking and exocytosis, follow-up studies to identify 
signaling pathways and proteins that are involved in these processes will also be of great 
importance.  
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APPENDIX A                                                                                                                              
SUPPLEMENTAL INFORMATION 
 
Figure A1 Localization of EB1 across en passant boutons 
A. Representative Z-stack images of a terminal co-expressed with EB1-RFP and Anf-GFP. En passant boutons are 
numbered from the most distal (#1) to proximal. B. Quantification of fluorescence relative to the most distal bouton 
(%F) (n=7).  Error bars represent S.E.M.  
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Movie S1. FRAP experiment showing preferential traffic to the distal bouton.  Timestamp shows time after 
photobleaching in minutes and seconds.  Scale bar, 2.5 μm.  
 
Movie S2. SPAIM experiment showing complex DCV movement to the distal bouton.  Scale bar, 5 μm. 
 
Movie S3. SPAIM experiment showing DCV efflux from the distal bouton. Scale bar, 5 μm. 
 
Movie S4. SPAIM experiment showing DCV efflux from a proximal bouton. Scale bar, 5 μm. 
 
Movie S5. SPAIM experiment showing retrograde flux at a branch point. Scale bar, 5 μm. 
 
Movie S6.  SPAIM experiment showing DCV flux at a proximal axon. Top, SPAIM experiment showing lack of 
generation of nascent DCVs following photobleaching of the soma and the AIS. Bottom, subsequently 
thepreparation was photobleached and imaged without photobleaching retrograde newcomers. Note the 
accumulation and reversal of DCVs in the AIS. 
 
Movie S7. SPAIM experiment showing the arrival and reversal of a retrograde DCV in the boxed region of 
the AIS. 
 
Movie S 8. Microtubule plus-end dynamic across en passant boutons.  
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